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Abstract 
During neurogenesis, the balance between factors promoting stem cell maintenance and those 
favoring cell differentiation, controls the transition from proliferative cell division to neurogenic 
cell division. Transcriptional and cell cycle regulators are key players of progenitor cell fate 
decision, and hence control the establishment of the neuronal networks which mediate cognitive 
functions later in life. Recent studies showed that imprinted genes regulate neurodevelopment 
and contribute to mental disorders. Here we show that the paternally expressed gene Zac1 might 
promote neuronal differentiation by functioning as a transactivator of the Tcf4 gene during 
neurogenesis.  
The Tcf4 gene encodes a basic helix–loop–helix (bHLH) transcription factor which belongs to the 
E-protein family. Tcf4 has been shown to mediate cell proliferation and migration. In addition, it 
is required for the neuronal differentiation of Math1-expressing populations in the hindbrain. In 
human, TCF4 plays a critical role during human brain development and in cognitive functions. 
Haploinsufficiency of TCF4 causes the Pitt Hopkins syndrome, and common variations in TCF4 
intragenic region were recently associated with schizophrenia and bipolar disorder. We showed 
that Zac1 coordinately binds to the proximal promoter and first intron of Tcf4 in vitro and in vivo 
and induces specifically its expression in several mouse neural cell types (embryonic stem cells, 
neural stem cells and mature neuronal populations) and adult neuronal population. We could also 
show that ZAC1, the human Zac1 orthologue activates TCF4 in vitro, suggesting conservation 
across species. Zac1 also regulates the expression of the Tcf4 target gene p57
kip2
 and hence, might 
control the cell cycle arrest and the migration of neuronal precursors in the developing brain.  
Altogether we could identify (to our knowledge) the first direct regulator of Tcf4 gene expression 
in the developing and adult brain. This suggests that the imprinted gene Zac1 might contribute to 
the brain development by promoting neuronal differentiation of specific progenitor populations.        
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I. Formation of the central nervous system (CNS) 
The CNS arises from the neural plate, a specialized region of the ectoderm that is the outermost 
of the three primitive germ layers. During embryonic development, the neural plate folds and 
forms the neural tube composed of neuroepithelial cells (NEP). Initially, the whole neural tube 
will differentiate into major subdivisions along an anterior-posterior axis giving rise to the brain 
and spinal cord. At first, the most anterior part of the neural tube differentiates into the three 
primary brain vesicles: the prosencephalon, the mesencephalon and the rhombencephalon. These 
vesicles are later subdivided into secondary vesicles, respectively: the telencephalon and 
diencephalon; the mesencephalon; the metencephalon and the myencephalon. The telencephalon 
gives rise to the neocortex dorsally and the basal ganglia ventrally. The resulting cavity forms the 
lateral ventricles. The diencephalon gives rise to the retina, the thalamus and the hypothalamus. 
The tectum originates from the mesencephalon. Finally, the metencephalon gives rise to the pons 
and the cerebellum, while the myencephalon differentiates into the medulla oblongata (Fig. 1). 
 
Figure 1: Formation of the brain. A) During development, the neural tube differentiates first into second, then third 
vesicles, which ultimately generate the different brains regions. The telencephalon and myelencephalon are the most 
rostral and caudal third vesicles, respectively. B) Rostrocaudal organization of the third vesicles. C) Scheme of the 
brain regions derived from the third vesicles, in a sagittal view. (Figure adapted from Carlson, 2004)  
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The central nervous system is composed of diverse cell subtypes whose spatio-temporal 
patterning is highly controlled and conserved during evolution. During brain development, all 
cell subtypes are generated from heterogeneous progenitors cells or neural stem cells which 
undergo sequential differentiation steps under the control of signaling molecules such as 
fibroblast growth factors (Fgfs), Wingless proteins (Wnts), sonic hedgehog (Shh), retinoic acid 
(RA), nodals, and bone morphogenic proteins (Bmps). In addition, cell differentiation is also 
under the control of intrinsic factors, as for instance specific combination of transcription factors 
in concert with epigenetic gene regulation which predispose the cells towards certain fates. 
 
II. Neural stem cells and neural progenitors 
The formation of the neural tube polarizes the cells with their apical side facing the inward zone 
which later becomes the ventricular zone (VZ) and their basal side facing towards the basal 
lamina and the pial surface (Götz and Huttner, 2005). NEP are characterized by the expression of 
different markers such as the intermediate filament Nestin (Lendahl et al., 1990), the SoxB1 
transcription factor family members Sox1, Sox2, and Sox3 (Wood and Episkopou, 1999). During 
mitosis, the nuclei of NEP migrate in a cell cycle dependent movement called Interkinetic 
Nuclear Migration - INM (apical to basal in G1, and basal-to-apical in G2), leading to the 
pseudo-stratification of the cell layers lining the ventricle (Taverna and Huttner, 2010). Before 
the onset of neurogenesis, all NEP expand via symmetric divisions and with the onset of 
neurogenesis, they switch to asymmetric mode of division to generate radial glial cells (RGC), 
basal progenitors (BP) also called intermediate progenitor cells (IPC) and post-mitotic neurons 
(preplate neurons) (Fig. 2) (Miyata et al., 2001, Haubensak et al., 2004; Miyata et al., 2004; 
Noctor et al., 2004). 
a) Radial glial cells  
RGC differentiate from NEP with the onset of neurogenesis, around embryonic day 10.5 (E.10.5) 
and acquire typical astrocytic features such as the presence of glycogen granules and the 
expression of astrocytic markers: the astrocytic specific glutamate and aspartate transporter 
(GLAST) (Shibata et al., 1997), the brain lipid-binding protein (BLBP) (Feng et al., 1994), 
Tenascin-C (Bartsch et al., 1992), the Ca2+ binding protein (S100ß) , Vimentin (Schnitzer et al., 
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1981) and in the dorsal telencephalon PAX6 (Götz et al., 1998; Heins et al., 2002). RGC exhibit 
apical–basal polarity and span the entire cortical wall. Their cell bodies are located at the most 
apical part of the cortical wall, with an apical process at the ventricular surface and a basal 
process at the pial surface. Their nuclei undergo INM and therefore RGC are, like NEP, layered 
in a pseudostratified epithelium manner (Kriegstein and Götz, 2003). In the telencephalon, RGC 
go through several rounds of mitosis and can therefore either increase the pool of multipotent 
proliferating cells upon clonal division or give rise to another RGC and to neuronal or glial 
progenitor after asymmetric cell division. These progenitors then migrate along their parental 
cell´s´ radial fibers (Malatesta et al., 2008) (Fig. 2). During development, the differentiation 
potential of the RGC is regulated in a temporal manner, as neurogenesis precedes gliogenesis and 
oligodendrogenesis. In later stages of brain development, the vast majority of RGC fully 
differentiate into astrocytes, except small populations located in specific niches, namely the 
subventricular zone (SVZ) of the lateral ventricules and the subgranular zone (SGZ) of the 
dentate gyrus (Lois and Alvarez-Buylla, 1993; Johansson et al., 1999; Alvarez-Buylla et al., 
2001; Merkle et al., 2004; Kempermann et al., 2004). These cells do not undergo terminal 
differentiation and maintain the ability to generate adult new born neurons and glia (Morrens et 
al., 2012). 
b) Intermediate Progenitor cells 
In the developing neocortex, ventral telencephalon and thalamus, cells are mainly born from 
RGC in the ventricular zone (VZ) but delaminate from that, and migrate in the basal direction to 
form a second layer of basal or intermediate progenitors cells (IPC), the sub-ventricular zone 
(SVZ) (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004; Wang et al., 2011). In the 
developing mammalian cortex, the SVZ is located between the VZ and the preplate (Fig. 2). IPC 
are characterized by the expression of the T-domain transcription factor Tbr2/Eomes (Englund et 
al., 2005). They loose their basal process and can undergo asymmetric mitosis only a few times, 
mainly generating a pair of neuronal precursors, and rarely a pair of IPC (Haubensak et al., 2004; 
Miyata et al., 2004; Noctor et al., 2004). Upon asymmetric division, their daughter cells are 
restricted to neuronal lineage and have a limited mitotic cycle of 1-3 cycles (Noctor et al., 2004). 
Hence, the SVZ contains progenitor cells and migrating neurons derived from the VZ and IPC 
(Fig. 1). In contrast to the progenitors derived from the RGC which can differentiate into neurons 
of all cortical layers, IPC are believed to generate mainly neuronal precursors fated to migrate 
and occupy the upper layers of the cortex (Arnold et al., 2008). This view is supported by the 
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expression in IPC of markers characteristic of upper layers neurons, such as the non-coding 
RNASvet1 (Tarabykin et al., 2001) and the homeodomain transcription factors Cux-1 and Cux-2 
(Nieto et al., 2004). In addition, phylogenic studies report that the enlargement of the SVZ during 
mammalian evolution parallels the expansion of the upper cortical layers (Cheung et al., 2010; 
Martínez-Cerdeño et al., 2006). 
 
Figure 2: The different cell populations during embryonic corticogenesis. With the onset of neurogenesis, NEP 
cells progressively convert to RGC that elongate following the thickening of the neural tube wall. IPC (outlined in 
red) are generated at early stages by NEP, and at later stages by RGC. They accumulate in the SVZ. Preplate neurons 
(green) are the first post-mitotic neurons generated during corticogenesis and delineate apically the SVZ. At later 
stages, neurons derive from both RGC (blue) and IPC, migrate towards the cortical plate (red) to form the 6 cortical 
layers. CP cortical plate; SVZ subventricular zone;VZ ventricular zone (Figure adapted from Malatesta et al, 2008). 
c) Proneural factors and E-proteins 
During brain development, many factors and signaling pathways have been shown to play a role 
in the differentiation of neural progenitors. Among others, the basic Helix-Loop-Helix (bHLH) 
factors are key controllers of the proliferation, specification, differentiation and migration of 
progenitors during neurogenesis (Cai et al., 2000; Ge, 2006). The bHHL factors are characterized 
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by the presence of a basic helix loop helix domain that allows them, upon homo- or hetero-
dimerization to bind to specific DNA sequences, the so-called E-Box (CANNTG) (Ephrussi et 
al., 1985; Murre et al., 1989). I will discuss here the role of the bHLH that play an important role 
in cell fate decision during corticogenesis, which includes the E-protein family and the proneural 
factors - Neurogenin, Mash, Math and NeuroD family members. 
The proneural factors are bHLH proteins whose expression promotes the differentiation of the 
neural stem cells. These factors are directly or indirectly capable of modulating cell cycle 
progression and initiate transcriptional cascades controlling the fate of the committed precursors 
(Farah et al., 2000; Bertrand et al., 2002; Ross et al., 2003; Castro et al., 2011). During brain 
development, there are 2 classes of factors promoting neurogenesis, the “specification” factors 
such as Neurogenins, Maths, Mashs and NeuroD factors, whose expression is spatiotemporally 
controlled, and their ubiquitously expressed dimerization partners, the E-proteins (Bertrand et al., 
2002; Bhattacharya and Baker, 2011). The specification factors control migration, specific 
neuronal fate acquisition (e.g glutamatergic vs GABAergic differentiation) and gain/loss of 
function studies highlighted their importance in the timing and in the control of cell fate 
(differentiation into neurons, astrocytes or oligodendrocytes (Lee et al., 1995; Cai et al., 2000; 
Fode et al., 2000; Tomita et al., 2000; Nieto et al., 2001; Parras et al., 2002; Parras et al., 2007). 
During development, proneural factors are expressed at low levels in proliferating 
undifferentiated progenitors. With the onset of neurogenesis the expression of specification 
factors (Neurogenin 1/2, Math1 and Mash1) and the E-protein family members (the two splice 
variants of E2A: E12 and E47, HEB and E2-2 also named Tcf4) increases. This results in the 
inhibition of the proliferation of progenitors, inhibition of astrogenesis (Sun et al., 2001) and in 
the induction of target genes, such as NeuroD genes which are required for terminal neuronal 
differentiation (Sun et al., 2001; Ross et al., 2003; Roybon et al., 2010).  
Many studies have tried to address how cellular diversity of the brain can be achieved when only 
few specification factors are expressed. The number of dimerization partners and their specific 
association during fate decision could provide a way to modulate proneural bHLH functions.  
The E-proteins were previously considered as non-specific cofactors of the specification factors. 
Indeed, in contrast to Neurogenin2 and Mash1 null mutants, HEB and E2A knockout mice did not 
display any gross morphological changes in brain anatomy, and these mutant mice exhibit higher 
expression of the other members of the E-proteins family. This suggests compensatory 
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mechanisms, where the dosage of E-protein and not the member identity is the key criteria to 
promote neuronal differentiation (Ravanpay and Olson, 2008). This view is supported by the fact 
that the 3 E-proteins are derived from a common ancestor (Daughterless) whose sequence was 
highly conserved throughout evolution and by the fact that their pattern of expression is 
overlapping during hematopoiesis and neurogenesis. In the hematopoietic lineage, where E-
proteins play an important role in B and T-Lymphocytes development (Murre, 2005), HEB 
driven by the endogenous E2A promoter can functionally replace E2A in supporting B-cell 
commitment and differentiation (Zhuang et al., 1998). In addition, in vitro studies in the embryo-
derived teratocarcinoma P19 cell line, showed that co-transfection of NeuroD2 in combination 
with each E-protein, promoted neuronal differentiation with the same efficiency (Ravanpay and 
Olson, 2008).  
The model of non-specific coactivating function of E-proteins was recently challenged by the 
study of Flora et al., which provided the first in vivo evidence for an exclusive function of dimers 
formed between a proneural bHLH factor and a specific E-protein (Flora et al., 2007). In this 
study, the authors identified a critical role for the heterodimer Tcf4/Math1 in the development of 
the mouse hindbrain. Interestingly in Tcf4 knockout mice, they observed deficits in migration and 
differentiation of rhombic lip-derived Math1
+
 progenitors in the pontine nucleus, that could not 
be compensated by the expression of the other E-proteins. Thus, Tcf4/Math1 heterodimers can 
exclusively activate specific differentiation programs required for pontine nucleus neurons. 
Altogether, the authors suggest the existence of two classes of neural progenitors in the 
developing hindbrain. The first class can differentiate when any one of the three E-proteins genes 
is deleted, because of functional compensation by the remaining E-proteins; and the second class 
requires the presence of Math1/Tcf4 heterodimers to activate the correct differentiation program. 
The authors propose that similar regulation occurs in specific neural progenitors in different 
regions of the developing neural tube, and that Tcf4 might additionally interact with various 
proneural bHLH such as the Mash1 (Persson et al., 2000b), or the NeuroD family members 
(Brzózka et al., 2010) to control brain development. 
This hypothesis is supported by the fact that TCF4 is critical for human nervous system 
development and cognitive function. Indeed, happloinsufficiency of TCF4 causes mental 
retardation and the Pitt-Hopkins syndrome, a neurodevelopmental disorder characterized by 
mental retardation, seizures and hyperventilation (Amiel et al., 2007; Brockschmidt et al., 2007; 
Zweier et al., 2007; Greenblatt et al., 2008; de Pontual et al., 2009; Rosenfeld et al., 2009; 
Marangi et al., 2011; Whalen et al., 2012). Moreover, a trinucleotide repeat in intron 3 and a 
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single nucleotide polymorphism (SNP) in intron 4 were associated with increased risk of 
developing bipolar disorder or schizophrenia in adulthood respectively (Breschel et al., 1997; Cai 
et al., 2000; Li et al., 2010; Steinberg et al., 2011). Thus, whilst severe dysfunction of TCF4 
causes developmental defects, subtle changes at its transcription level might predispose to 
psychiatric diseases.        
Altogether this suggests that E-proteins are partly redundant during development and that the 
control of their expression is of particular relevance to coordinate the transcription mechanisms 
controlling neuronal differentiation. 
 
d) Repressors of neurogenesis and maintenance of pluripotency by Hes and Id 
proteins 
At the onset of neurogenesis, the expression of proneural bHLH factors transiently increases to 
induce differentiation of specific progenitors. To counteract the neurogenic effect of proneural 
factors, and prevent the simultaneous differentiation of all progenitors in the VZ, the 
differentiating cells maintain the adjacent cells in undifferentiated state by a process called lateral 
inhibition (Artavanis-Tsakonas et al., 1999; Lai, 2004). Neuronal precursors express the Notch 
ligand at their surface which activates the Notch signaling pathway in the adjacent cells, inducing 
the expression of the repressor of the proneural genes, the Hes genes. The Hes genes are the 
mammalian homologues of Drosophila hairy and Enhancer of split. Upon activation of the 
transmembrane receptor Notch by its ligand Delta-like protein 1 (Dll1), the Notch intracellular 
domain (NICD) is released from the membrane and translocated to the nucleus where it forms a 
complex with RBP-J. The complex RBP-J/NICD acts as a transcriptional activator; whilst in 
absence of NICD, RBP-J functions as a repressor of Hes1 and Hes5 genes (Jarriault et al., 1995; 
Kopan and Ilagan, 2009; Imayoshi et al., 2010).  
The lateral inhibition model is considered to explain the opposite pattern of Hes1 and the Notch 
ligand Dll1 expression in the nervous system during early ontogeny (Bettenhausen et al., 1995; 
Hatakeyama and Kageyama, 2006). This model, also called “salt-and-pepper” model states that at 
early stages, neural progenitors express similar levels of Dll1 and proneural genes. However, 
some cells express higher levels of Dll1, due to stochastic events, and activate more efficiently 
the notch signaling in the adjacent cells. The latter cells express then higher levels of Hes1 and 
Hes5, which lead to the lower expression of the proneural genes and Notch ligands, and 
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maintenance of stemness. Consequently, the former cells are less activated by Notch ligands, 
which induces the expression of proneural genes and Notch ligand, ultimately promoting 
neuronal differentiation. 
However, recent observations that Hes1 expression oscillates with a period of about 2-3 hours in 
neural precursors, which in turn induces the inverse oscillation of Dll1 and Neurogenin2 
expression, have added another layer of complexity to the lateral inhibition model (Kageyama et 
al., 2008; Shimojo et al., 2008). By contrast, Hes5 expression does not seem to oscillate, and is 
independent in NEP on Notch canonical pathway, but is first induced by active DNA 
demethylation of its promoter (Hitoshi et al., 2011).  
Hes1 and Hes5 genes are the direct effectors of Notch signaling during brain development and 
play key roles in the development of the telencephalon, where they can sustain progenitors in an 
undifferentiated, proliferative state and inhibit their neuronal differentiation (Ishibashi et al., 
1995; Nakamura et al., 2000; Ohtsuka, 2001; Hatakeyama, 2004; Mizutani et al., 2007). They act 
as repressor of gene expression by recruiting repressor complexes such as Groucho/TLE to their 
target gene promoters (Yao et al., 2001), where they can either directly bind to DNA elements 
called N boxes (CACNAG) (Takebayashi et al., 1994) or can be tethered  by other transcription 
factors. Their targets include, among others, key regulators of differentiation of glutamatergic and 
GABAergic neurons, namely Neurogenin2 and Mash1 (Baek, 2006; Holmberg et al., 2008; 
Imayoshi et al., 2008). Hes5 was also showed to heterodimerize in vitro with the E-protein E47, 
sequestrating it from its interacting proneural factor and hence, inhibits the transcriptional activity 
of the complex E-protein/proneural factor (Akazawa et al., 1992). However, recent experiments 
in vivo argue against this mechanism and rather favor the view that Hes proteins act as 
transcriptional repressors of proneural genes during neurogenesis (Holmberg et al., 2008).  
 
Like Hes1 and Hes5, Id genes can inhibit neurogenesis via two mechanisms: either by sustaining 
Hes1 expression in neural stem cells (NSC) (Bai et al., 2007), or by competiting with the E-
proteins for binding to the proneural factors (Jung et al., 2010). Id proteins possess a helix-loop-
helix domain but lack the basic domain required for DNA binding. Hence, they can form 
heterodimers with other bHLH factors or their dimerization partners, the E-proteins; and prevent 
the binding of proneural/E-protein complexes to the promoter of their target genes (Jen et al., 
1992; Kreider et al., 1992). During brain development, Id1, Id2 and Id3 are abundantly expressed 
in proliferating NEP (Tzeng, 2003) and facilitate self-renewal and proliferation of NSC by 
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inhibiting the transcriptional cascade controlled by proneural factors (Lyden et al., 1999; Jung et 
al., 2010). 
During brain development, the cross-regulation of the proneural factors and pluripotency factors 
and their relative proportion determine both the cell fate and the timing of differentiation. Before 
the onset of neurogenesis, Hes and Id activity promotes proliferation of neural progenitors and 
inhibits the expression of neurogenic factors. Upon onset of neurogenesis, progenitors exit the 
cell cycle and concomitantly a transient increase in the expression of proneural bHLH factors and 
their dimerization partners, the E-proteins triggers the sequential expression of specification 
bHLH factors, ultimately leading to the generation of distinct neuronal populations.  
In the last decade, several studies revealed the importance of transcription factors during 
neurogenesis; however it has now become clear that many gene families control brain 
development. Among them, the imprinted genes were identified as important regulators of 
cognitive function and brain development.      
  
III. Brain development and imprinted genes 
In 1984, Barton et al. in the UK (Barton et al. 1984) and Mcgrath and Solter in the USA 
(McGrath and Solter, 1984) discovered that parthenogenetic (PG) and androgenetic (AG) 
embryos (having two maternal or paternal genome copies respectively) do not complete 
embryogenesis. AG embryos died at the 8-somite stage and displayed retarded embryonic growth 
and extra-embryonic tissue overgrowth. PG embryos died at the 25-somite stage and exhibited 
reduced extra-embryonic tissue growth. The authors concluded that the maternal and paternal 
contributions to the embryonic genome in mammals are not equivalent, and that a diploid 
genome derived from only one of the two parental sexes is incapable of supporting complete 
embryogenesis. This discovery suggested that genes expressed from the paternal allele might 
have different functions than those expressed by the maternal allele, hinting for a differential 
contribution of the parental genomes to the embryonic development. These genes were identified 
later as expressed in a parent-of-origin-specific manner and named imprinted genes (IG) (Barlow 
et al. 1991). The molecular and cellular mechanisms underlying imprinting have been extensively 
studied, and it was shown that allele-specific expression is mediated by different epigenetic 
modifications on the two parental chromosomes (DNA methylation and Histone tail 
modifications). These modifications are established during gametogenesis and are maintained 
throughout life (Bartolomei and Ferguson-Smith, 2011; Kaneda, 2011). Furthermore, IG 
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expression is thought to be highly susceptible to environmental conditions (e.g dietary, stress) 
that could modify the epigenetic mark controlling the allele specific expression (Jaenisch and 
Bird, 2003).   
Since the discovery of the paternally expressed Igf2 gene and maternally expressed Igf2r and H19 
genes in 1991 (Barlow et al., 1991; DeChiara et al., 1991), approximately 100 IG have been 
identified. Recently, using new-generation sequencing methods for high-resolution of mouse 
brain transcriptome, Gregg et al. identified over 1300 RNAs (protein-coding and putative non 
coding) showing a parental bias in expression; suggesting that the number of IG is much higher 
than expected (Gregg et al., 2010a). However to accept all these genes as bona fide IG, the 
precise epigenetic mechanisms governing their biased expression need to be identified. The 
rationale of imprinting is still under debate with the most developed theory being the conflict 
theory (or kinship theory) (Haig and Westoby, 1989). According to this concept, imprinting 
developed from a genetic conflict between paternal and maternal genome interests (Haig and 
Westoby, 1989; Haig and Graham, 1991; Moore and Haig, 1991). In this model, genomic 
imprinting has evolved in species where females carry the offspring of more than one male 
during their life span and provide most of the post-fertilization nutrition. The father´s interests are 
to promote the survival and the reproductive success of his progeny over other´s, whereas 
mother´s interests are to equally provide resources between the different offsprings whilst 
maintaining enough resources available for further pregnancies. Therefore paternal genes are 
expected to maximize resources received from the mother and to promote maternal care to an 
individual offspring; whereas maternal genes restrain resource acquisition and maternal 
provisioning (Haig, 1997; Haig, 2004). The antagonistic function of IG in resource acquisition is 
further supported by the number of imprinted genes regulating placental function, in utero growth 
and the suckling behavior (Itier et al., 1998; Lefebvre et al., 1998; Li, 1999; Plagge et al., 2004; 
Isles and Holland, 2005). 
 
IV. Genomic imprinting plays key roles in brain function  
Imprinting has been clearly linked to social behavior and human cognitive function through 
studies of Prader-Willi syndrome (PWS) and Angelman syndrome (AS), which result from a 
paternally or maternally inherited deletion of an imprinted gene cluster (including Snrp, UBE3A 
and Necdin genes) on the same chromosomal region 15q11-13 (Cassidy et al., 2000). PWS is 
Introduction 
 
13 
 
associated with hypotonia, hyperphagia, hypogonadotrophic phenotype, stubbornness and 
compulsive traits (Cassidy et al., 2011), whereas AS is associated with absence of speech, ataxia, 
happy demeanor and inappropriate laughter (Williams et al., 2006). Interestingly, individuals 
with Angelman syndrome have anatomical brain abnormalities including cortical atrophy 
(Dörries et al., 1988), Purkinje cell loss and ventricular enlargement (Jay et al., 1991), indicating 
that IG play a role during brain development and brain structure organization. 
The specific effect of IG on brain size and organization was previously demonstrated using 
chimeric mice (Allen et al., 1995) generated by aggregating wild type (WT) cells with PG or AG 
cells. Both types of chimera survived but they had different phenotypes: The brain, especially the 
forebrain of PG mice, was larger than WT brains, in contrast to the AG mice brains that were 
smaller. This study also demonstrated that during neurogenesis, AG and PG cells distributed in 
the brain in distinct patterns: AG cells preferentially localized to the hypothalamus (especially in 
the preoptic area), septum and the bed nucleus of stria terminalis whereas PG cells were mainly 
found in the striatum, hippocampus and neocortex. This study indicated a role of the imprinted 
genes in neurodevelopment and further suggested that the paternal and the maternal genomes 
may impact differentially on distinct brain systems.  
Comprehensive studies of the expression pattern of IG in the brain revealed that these genes show 
a substantial variability in their spatio-temporal expression but also in some case, in their 
imprinting status (Gregg et al., 2010a; Gregg et al., 2010b); which might be an additional level of 
fine-tuning of the IG function. The dynamic nature of IG gene expression in the developing brain 
also suggests that these genes might be required for differentiation or proliferation of neural 
progenitors. However, although the expression of IG in the brain has been extensively studied, 
for most of them their functions and mechanisms of action during neurogenesis remain unclear.  
For few genes, the mechanism of action has been identified by loss of function approaches which 
revealed that the paternally expressed genes Peg3 and Necdin and the maternally expressed gene 
Cdkn1c/p57
kip2
 have profound impacts on brain development. For instance, the paternally 
expressed putative transcription factor Peg3 is required for the generation of oxytocin neurons in 
the hypothalamus. Necdin enhances the differentiation of GABAergic neurons in the forebrain 
(Kuwajima et al., 2006) and is required for the development of gonadotropin-releasing hormone 
(GnRH) neurons in the hypothalamus (Miller et al., 2009). The cyclin kinase inhibitor p57
kip2
 
coordinates multiple stages of corticogenesis by controlling the proliferation, differentiation and 
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migration of neural precursors (Tury et al., 2011a). These examples indicate that, like proneural 
genes, IG are important factor controlling brain development. 
 
V. The paternally expressed gene Zac1 as regulator of embryonic 
development 
In 1997, Spengler et al, using a functional expression cloning technique (Spengler et al., 1993), 
isolated two factors capable of activating the type I PACAP receptor in a kidney epithelial cell 
line: p53 and a new zinc finger protein (Spengler et al., 1997). Like p53, this factor can 
concomitantly induce apoptosis and regulates cell cycle progression in a p53-dependent (Huang 
et al., 2001) and independent manner (Kamikihara et al., 2005), and was named after its function: 
Zinc finger protein regulator of Apoptosis and cell Cycle arrest 1 (Zac1). The rat orthologue of 
Zac1, Lot1 (for Lost-On-Transformation) was identified in malignantly transformed rat ovarian 
surface epithelial cells (Abdollahi et al., 1997a) whilst the human orthologue ZAC1 was 
discovered in 1998 and mapped to the chromosome 6q24-25, a region frequently deleted in solid 
tumors of different tissues (Varrault et al., 1998). Interestingly, loss of ZAC1 expression has been 
observed in numerous tumor types, including breast tumors, ovary tumors and pituitary adenomas 
(Abdollahi et al., 1997b; Bilanges et al., 1999; Pagotto et al., 2000; Cvetkovic et al., 2004; 
Basyuk et al., 2005). Finally, Zac1 inhibits tumor formation in nude mice (Spengler, 1997), 
suggesting a function for Zac1 as tumor suppressor.  
ZAC1 is a member of the Pleiomorphic Adenoma Gene (PLAG) family (Kas, 1998), and is also 
named PLAGL1 (Pleiomorphic Adenoma Gene-Like 1) due to its structure analogy with the 
member of the PLAG family, PLAG1 and PLAGL2. These three members are structurally similar 
but appear to have different functions. Indeed, Zac1/Lot1/ZAC1 is a candidate tumor suppressor 
gene, whereas PLAG1 and PLAGL2 are proto-oncogenes (Kas et al., 1997; Zheng et al., 2010). In 
this dissertation, Zac1 will refer to the mouse gene while ZAC1/PLAGL1 and Lot1 refers to the 
human and the rat orthologues, respectively. 
 
a) Zac1/Lot1/PLAGL1 protein structure 
Zac1 is located on chromosome 10 and its transcripts are spliced from 10 exons (Piras et al., 
2000), where the last two are coding for a 693 or 704 amino acids long protein (Spengler, 1997; 
Warzée et al., 2010). Zac1 contains seven N-terminal C2H2 zinc-fingers required for DNA 
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binding to palindromic elements or direct repeats elements (Fig. 3). The linker Proline-Rich 
region (LPR) confers transactivational activity to Zac1. The C-terminal domain, together with the 
zinc finger domain, can recruit the general coactivator p300 and modify its HAT activity 
(Hoffmann et al., 2003; Hoffmann et al., 2006).  
Lot1 encodes a 583 amino acid long protein and present the same structure as Zac1, however it 
does not contain the proline rich tripeptides motifs (PLE, PMQ or PML) (Abdollahi et al., 
1997a). ZAC1 codes for a 463 amino-acid protein that also shares a strong homology with Zac1, 
yet it lacks the proline rich tripeptide motifs, and the C-terminal regions rich in P,Q,L residues 
and PE,E repeats (Fig. 3). Despite these structural differences, Zac1 and ZAC1 seem to have 
similar functions in apoptosis and growth inhibition (Bilanges et al., 1999).      
 
 
Figure 3: Structure and transcriptional activities of Zac1. A) Scheme of Zac1 proteins. Numbers denote amino 
acids, and domains are boxed. The homology (%) between mouse (Zac1) and human (ZAC1) proteins is indicated. 
Mouse Zac1 and human ZAC1 protein possess identical zinc-finger domains (ZF) that are involved in DNA-binding. 
The linker (L) confers transactivation in conjunction with the proline-repeat (PR) domain which exists solely in 
mouse. The coactivator-binding domain (CB) can recruit the general coactivators p300/CBP. B) Model of Zac1 
transcriptional activities based on differential DNA-binding. Zac1 binding as a monomer to the palindrome G4C4, via 
zinc finger 6 and 7 confers transactivation. DNA binding occurs by multiple zinc finger contacts, including zinc 
fingers 2 to 4, 6, and 7. Zac1 binding to the direct repeat element (G4N6G4)2 promotes dimerization through zinc 
Introduction 
 
16 
 
finger 2 and transactivation. Multiple zinc fingers, including 2 to 4, 6, and 7, contribute to DNA binding. Zac1 
binding to one half-site of the direct repeat element confers repression instead of transactivation (Figures modified 
from Theodoropoulou et al. 2010).  
b) Expression pattern of Zac1  
i. During development  
Zac1 is abundantly expressed in the developing nervous system as well as in non-neural tissues 
including the myocardium, skeletal muscle, chondrogenic tissue, body wall of the umbilical 
region, limb buds, branchial arches, liver primordium, pancreas and somites (Valente and 
Auladell, 2001; Tsuda et al., 2004; Alam et al., 2005; Valente et al., 2005; Yuasa et al., 2010; Du 
et al., 2011) (Table 1). In the developing brain, between E9.5 and E15, Zac1 is expressed in 
regions with active cellular proliferation such as the ventricular zone of the third and fourth 
ventricles (Alam et al., 2005; Chung et al., 2011) and the developing retina (Ma et al., 2007a). In 
the telencephalon, the expression of Zac1 is mainly restricted to dividing progenitors and is 
patterned into a dorsal-ventral gradient with a highest expression in the dorsal cortical domains 
(Alam et al., 2005) indicating a role for Zac1 in corticogenesis (Mattar et al., 2008). Zac1 is also 
expressed in differentiating areas such as the cortical preplate, deep layer of the cortex (III-IV), 
the arcuate nucleus and the amygdaloid region (Valente and Auladell, 2001). In the cerebellum, 
Zac1 is expressed in the ventricular zone overlying the fourth ventricle, in the external granular 
cell layer (EGL), in differentiating GABAergic interneurons and a subset of Golgi cells (Chung et 
al., 2011). 
From E15 until postnatal day 0 (P0), Zac1 expression remains strong in the differentiating areas, 
where it was expressed earlier and in the different germinative layers of the brain: VZ and EGL 
of the cerebellum (Valente and Auladell, 2001; Chung et al., 2011). In the cortex, Zac1 is 
expressed at much reduced levels in the SVZ, and at intermediate levels in a band of cells in the 
developing cortical plate (Alam et al., 2005).  
ii. At postnatal stages 
In adult mice, Zac1 is highly expressed in the anterior pituitary, in chondrogenic sites, at diverse 
levels in the brain, and faintly in peripheral tissue, such as stomach, kidney, adrenal gland, heart 
and lung (Spengler, 1997; Valente and Auladell, 2001). 
After birth Zac1 expression decreases in the VZ and the SVZ but increases in certain neuronal 
populations, as for instance in the pyramidal neurons of the CA3 of the hippocampus and in the 
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migrating neurons in the rostral migratory stream. Moreover its expression increases in 
differentiated neurons of the amydgaloid area, in the arcuate nucleus and other hypothalamic 
nuclei (Valente and Auladell, 2001). In the cerebellum, Zac1 is transiently expressed in the EGL 
and its derivatives (in a subset of Purkinje cells, and in GABAergic interneurons) from P0 until 
P20; suggesting a role for Zac1 in the differentiation/maturation of specific GABAergic 
population of the cerebellum (Valente and Auladell, 2001; Chung et al., 2011). Interestingly, 
Lot1 is transiently expressed in the developing suprachiasmatic nucleus from P1 until P20, where 
its expression shows a circadian rhythm peaking at day time, suggesting a role for Lot1 in 
maturation of suprachiasmatic nucleus (SCN) neurons (Maebayashi et al., 1999).  
Hence the pattern of expression in progenitors and differentiated cells suggests that Zac1 plays a 
role in both control of proliferation, consistent with its role as cell cycle regulator, but also in 
differentiation of specific neuronal subpopulations. However, the precise molecular mechanism 
by which Zac1 regulates neurogenesis is still unknown. 
c) Imprinting of Zac1 
Transient neonatal diabetes mellitus (TNDM) is a rare condition characterized by intrauterine 
growth retardation, dehydration and hyperglycemia due to low levels of insulin secreted during 
the first months after birth (Shield et al., 1997). Despite an apparent remission by 3 months, there 
is a tendency for children to develop diabetes in later life (Temple, 2002). In 1995, Temple et al. 
(Temple et al., 1995) reported that TNDM is associated with paternal uniparental disomy of the 
human chromosome 6, thus suggesting a pathogenetic role for imprinted genes. This was further 
supported by the discovery that patients with paternal disomy of the chromosome 6, duplication 
of paternal 6q (Temple, 1996) and methylation defect on the maternal allele (Gardner, 2000) 
present the same phenotype. The genomic region associated with TNDM was further defined 
(Temple, 1996) and two paternally-expressed candidate genes were identified: ZAC1 and the non 
coding RNA HYMAI (Arima et al., 2000; Kamiya, 2000) whose exclusive paternal expression 
relies on DNA methylation in the promoter region of the maternal allele (Arima, 2001; Mackay et 
al., 2002; Arima et al., 2006). This differentially methylated region (DMR) is a so called 
imprinting control region (ICR) that mediates the parent-of-origin specific expression. Zac1 ICR 
harbors a CpG island where the maternal allele is methylated (preventing its expression) and 
where the paternal is devoid of methylation and can be expressed (Fig. 4). Therefore, duplication 
of the paternal allele, or defects in methylation of the maternal allele on chromosome 6, result in 
overexpression of the ZAC1/HYMAI genes which causes TNDM. The role of ZAC1/HYMAI in 
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TNDM was also evidenced by the study of Ma et al, (Ma et al., 2004) in which transgenic mice 
harboring the human TNDM locus upon paternal transmission display, hyperglycemia in 
neonates which resolves in juvenile mice and impaired glucose tolerance in adult. Overexpression 
of ZAC1/HYMAI in these transgenic mice recapitulated the key features of TNDM and implicated 
a role for ZAC1/HYMAI in pancreatic beta-cells development and function (Ma et al., 2004). 
 
Figure 4: Paternal expression of the imprinted gene Zac1. A) Imprinted genes are expressed in a parent-of origin 
manner. Most of the genes are biallelically expressed (green boxes). Only a small subset of genes is exclusively 
expressed either from the maternal (Mat) or paternal (Pat) allele. These genes are named imprinted genes. B) The 
paternal expression of the Zac1 and HYMAI genes is mediated by a differential cytosine methylation in the imprinted 
control region (ICR). The ICR of Zac1/HYMAI is a CpG island which is located in the promoter of the 
Zac1/HYMAI genes. The ICR is highly methylated on the maternal allele ( ), which prevents the Zac1/HYMAI 
gene expression; whereas it is devoid of methylation on the paternal allele ( ), which enables gene transcription.      
d) Biological function of Zac1 
The mechanism of imprinting is conserved between mouse and human (Arima et al., 2006) and 
therefore, knockout mice (KO) can be obtained by inactivating the Zac1 paternal allele. Varrault 
et al (Varrault et al., 2006) used this approach to create Zac1 KO (Zac1
+/-pat
). Zac1 mutant mice 
show intrauterine growth retardation, impaired bone formation, lung defects and neonatal 
lethality. Interestingly, in contrary to what is expected from a tumor suppressor gene with 
proapoptotic and cell-cycle-blocking activities, KO of Zac1 resulted in embryonic growth 
restriction. This is however consistent with the kinship theory of imprinting, where paternally 
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expressed genes are growth-promoting. Hence, the authors suggest that number of genes have 
been evolutionally selected to be imprinted according to their physiological properties rather than 
their molecular functions (Varrault et al., 2006). 
To gain insight into the function of Zac1, Varrault et al. (Varrault et al., 2006) compared 
microarray data sets to identify genes that were co-expressed with Zac1. They identified an 
imprinted gene network (IGN) which controls embryonic growth and differentiation, and where 
the downregulation of Zac1 alters the expression of several other imprinted genes such as 
p57
kip2
/Cdkn1c, IGF2, H19 and Dlk1 (Fig. 5). They further showed that Zac1 directly controls the 
expression of IGF2 and H19 by binding to their shared enhancer E2 on chromosome 7; however 
they could not identify by which mechanism Zac1 acts on the other imprinted genes. 
 
 
Figure 5: Zac1 belongs to an imprinted gene network. Genes co-expressed with imprinted genes, including Zac1, 
were deduced from a body of 116 microarray data sets. 246 genes linked to at least three imprinted genes were then 
selected. The links between genes have different gray densities according to the number of data sets in which the 
genes are coregulated (light gray = 4 to black = 10). (Varrault et al. 2006) (Varrault et al., 2006). 
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Table 1: Expression pattern of Zac1 during mouse embryonic development and postnatally. The intensity of the 
signal detected by in situ hybridization (ISH) using a mouse Zac1 cDNA  riboprobe is indicated. (Valente and 
Auladell, 2001). 
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e) Zac1 as regulator of progenitor cell differentiation   
Accruing evidence describes a role for Zac1 function in the control of progenitor cell fate during 
development. Indeed, it was recently identified as an essential transcription factor for cardiac 
morphogenesis (Yuasa et al., 2010) and for neurogenesis in the retina (Ma et al., 2007a; Ma et al., 
2007b). Zac1 also regulates, upon PACAP activation, the proliferation of neuronal precursors in 
the developing cerebellum (Fila et al., 2009); and is necessary for the differentiation of distinct 
GABAergic neuronal populations in the cerebellum (Chung et al., 2011).  
An unpublished work of Tony Valente describes in more details the effects of Zac1 KO on 
murine brain development. Mutant mice had smaller brains, displayed in some cases 
hydrocephalia and increased mitotic activity in the VZ and SVZ of the lateral and third ventricles. 
Changes in neuronal and glial cell population ratio (especially GABAergic interneurons, 
catecholaminergic neurons and oligodendrocytes) were observed, supporting a role for Zac1 in 
the proliferation and differentiation of specific neural progenitors during brain development 
(http://www.tesisenred.net/bitstream/handle/10803/840/2.RESULTADOS.pdf?sequence=3). 
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Aim of the thesis 
The paternally expressed gene Zac1/ZAC1 has been previously identified as a cell cycle 
regulator. Interestingly, it acts as a transcription factor, which, like proneural genes, shows a 
dynamic expression in the neuroepithelia of the developing brain. Zac1 is part of an imprinted 
gene network that regulates embryonic growth and was recently shown to control the 
proliferation and/or the differentiation of distinct neural progenitors. However, the molecular 
mechanism by which Zac1 might regulate neurogenesis has not been addressed yet. As Zac1 
functions as a transcription factor, we hypothesized that identifying its transcriptional targets 
would help to better understand how Zac1 participates in progenitor cell fate decision. To 
identify Zac1 target genes, we used the same approach as described in the study of Barz et al. 
(Barz et al., 2001). We applied genome-wide expression analysis and identified, among others, 
the E-protein Tcf4 as putative Zac1 target gene. The aim of the work presented here was to 
validate the dimerization partner of proneural factors, Tcf4, as direct Zac1 target gene and to 
investigate how this regulation could contribute to brain development. 
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Materials and Methods  
I. Materials 
a) Molecular biology 
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b) Cell culture materials 
 
c) Antibodies 
I. Primary antibodies 
 
II. Secondary antibodies 
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II. Methods 
a) Animals 
All animals used in these experiments (C57BL/6N and Cd1 mice) were obtained from Charles 
River Laboratory (Charles River, Sulzfeld, Germany), upon arrival they were housed, at the 
animal facility of Max-Planck Institute of Psychiatry, under standard conditions [temperature 
controlled (21°C) environment and 12h light:12h dark cycle (lights on at 06:00)]. For 
neurospheres and primary embryonic cultures, female Cd1 mice were checked daily at 7:00 am 
and those that had mated, as evidenced by the existence of a vaginal plug, were then housed with 
other pregnant mice. The positive plug date was termed E1. For postnatal cerebellar neuronal 
cultures, male and female Cd1 juvenile mice were housed with the mother; the date of birth was 
termed P1. 
b) DNA analysis 
I. PCR reaction  
Standard PCR were performed in Biometra T-Gradient thermocyclers (Biometra, Germany) using 
Fermentas Taq polymerase (Thermo scientific). PCR reaction mix was prepared as followed : 2 
μl template, 2.5 μl 10×reaction buffer, 1.5 μl dNTPs (10 mM each), 0.5 μl forward primer (10 
pmol/μl), 0.5 μl reverse primer (10 pmol/μl), 4 μl MgCl2  (25 mM), 1U Taq polymerase, distilled 
water to 25 μl. If not indicated otherwise, the following PCR conditions were used: Initial 
denaturation (95 °C, 3 min); then 35 cycles [denaturation (95 °C; 1 min) – annealing (see table 3 
for annealing temperatures; 30s) – elongation (72 °C; 1 min)]; then final elongation (72 °C, 5 
min). 
II. Agarose gel electrophoresis 
Agarose gel electrophoresis was used to analyse the quality of DNA and to separate fragments by 
size. Depending on the size of the DNA molecules, agarose solutions were prepared ranging from 
0.8 to 2% (w/v) in 1 x TBE buffer (90 mM Tris, 90 mM Boric acid, 2 mM EDTA). Ethidium 
bromide was added to a final concentration of 0.25 μg/ml. The samples to be analysed were 
mixed with 1x loading dye (6x loading dye: 40% v/v sucrose, 0.25% xylene cyanol, and 0.25% 
bromophenol blue). The voltage applied depended on the distance between the electrodes. In 
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general, the voltage applied was between 4 and 6 V/cm. As size standard, a 1kb DNA ladder 
(Invitrogen) was used. DNA or RNA was visualized under UV light. 
III. Recovery of DNA from agarose gels  
The desired DNA band was cut out from an electrophoresis-grade agarose gel under UV light and 
transferred into a 1.5 ml tube. The Macherey-Nagel PCR purification kit was used to recover the 
DNA fragment from the gel. NT buffer was added to the tube which was incubated at 65 °C on a 
thermomixer (Eppendorf, Germany) with gentle shaking until gel melting. The mixture was 
transferred to a PCR purification column. After purification, DNA was eluted in 15 µl TE buffer.   
c) RNA analysis  
I. RNA isolation 
Total RNAs from brain tissues or cell lines were isolated using the Nucleospin RNA II kit 
(Macherey Nagel). All plastic and glassware and the pestle used were autoclaved before use to 
inactivate RNases. Brain tissues were first crushed using a pestle and resuspended in lysis buffer. 
The homogenate was then further passed several times through a hypodermic syringe (29G), and 
processed following manufacturer´s protocol. RNA was eluted in 30 µl DEPC-treated water and 
RNA concentrations were measured spectrophotometrically using the Nanodrop. 
II. cDNA synthesis and subsequent gene-specific PCR  
A total volume of 20 μl was used for cDNA synthesis reaction using the RevertAid™ Premium 
Reverse Transcriptase (Thermo scientific). Total RNA (200 ng) was subjected to a reverse 
transcription reaction in the presence of 1 μl oligo (dT)18 (100 pm), 1 μl dNTPs (10 mM each) 
and adding sterile water to 12 μl. Then the mixture was heated to 65 °C for 5 minutes and quick 
chilled on ice. The contents of the tube were collected by brief centrifugation before adding 5× 
RT buffer, 1 µl Ribolock
Tm 
RNase inhibitor (Thermo scientific) and 1 µl RevertAid™ Premium 
Reverse to the reaction. The samples were incubated first 10 minutes at 25 °C, then 40 minutes at 
50 °C. Finally, the reaction was inactivated by heating at 85 °C for 5 minutes. The cDNA was 
used as template for amplification in PCR reactions. 
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III. Quantitative PCR analysis 
mRNA expression levels and DNA amounts precipitated during Chromatin immunoprecipitation 
(ChIP) were analysed by quantitative Real Time PCR, using the Absolute Blue QPCR Sybr green 
mix (ABgene) and the MJ Mini Opticon light cycler (Bio-Rad). All experiments were performed 
according to manufacturer’s instructions. The primers used for qRT-PCR were designed across 
exons to avoid genomic DNA amplification. The different primers used are listed (Table 2) and 
experiments were performed in triplicates. Fluorescence was assessed each cycle after elongation 
phase. At the end of each run, a melting curve (50-95 °C with 0.05 °C/sec) was generated to 
evaluate the quality of the PCR product. Cycle threshold values (Ct values) were determined 
using the Opticon monitor 3 software (Biorad). Threshold and noise band were set in all 
compared runs to the same level. Relative gene expression was determined by the 2
-ΔCT
 method 
(Livak and Schmittgen, 2001) using the real PCR efficiency calculated from an external standard 
curve and normalized to the expression of the house keeping gene Mas. 
 
Table 2: Primers used for RT-PCR, real time qRT-PCR and ChIP analysis. 
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d) Plasmids 
I. Reporter constructs 
pGL3-Tcf4prom: The promoter region of the mouse Tcf4 gene (NM_013685.2) (-887 bp until 
+46 bp) was amplified by PCR from Bl6 mouse kidney genomic DNA. The primers used for this 
PCR reaction contained a MluI site in the forward primer (5´-ATT ACG CGT GGT GTT AAG 
GAT GTG AA-3´) and a BglII site in the reverse primer (5´-CTT AGA TCT GTA ATC CAT 
TCA CAT CCG GGC-3´). The PCR product was first cloned into pGEM-T (Promega) vector and 
verified by sequencing. The mouse Tcf4 promoter fragment was released from the pGEM-T-
Tcf4prom vector by MluI and BglII double digestion. Meanwhile, PGL-3 basic vector (Promega) 
was also double digested with MluI and BglII (all restriction enzymes were obtained from 
Thermo scientific), and dephosphorylated by adding 1U of calf intestinal alkaline phosphatase 
(CIAP) to avoid recircularization of the vector. After purification on electrophoresis grade 
agarose gel, the Tcf4 promoter fragment and pGL3 basic vector were ligated at a ratio 2:1 
overnight at 4 °C. After ligation, plasmid DNA was precipitated by adding 1 µl glycogen, 1 µl 
NaAc and 2 volumes of pure ethanol to the ligation mix and placing it in liquid nitrogen for 1 
min. Samples were then centrifuged at 4 °C (12000 g, 20 min), and the pellet was washed by 
70% ethanol prior to another centrifugation step (4 °C, 12000 g, 10 min) to pellet desalted 
plasmid DNA. Plasmid DNA was resuspended in 10 µl TE buffer and 5 µl were used for 
transformation. DH5 bacteria were transformed with ligation product and plated on agar plate 
overnight at 37°C. Plasmid DNA was amplified by miniprep preparation and the presence of the 
insert upstream of the luciferase reporter gene in the MluI/BglII sites of the PGL3 basic vector 
was assessed by enzymatic restriction mapping. Positive clones were amplified and DNA isolated 
from maxiprep was used in transfection assay. pGL3-Tcf4intr1 – The DNA fragment coding for 
a part of intron 1 of the mouse Tcf4 gene (+1087/+2754 bp) was amplified by PCR from Bl6 
mouse kidney genomic DNA using the accuprime GC-rich polymerase (Invitrogen). The primers 
used for this PCR reaction included MluI site in the forward primer (5´-TTC ACG CGT ATG 
TGC ATG GGT TTC TGT ATG G-3´) and a BglII site in the reverse primer (5´-CAA AGA TCT 
CCT AGA AAC ATG GAA ATA ACC GC-3´). The PCR product was first cloned into pGEM-T 
vector and verified by sequencing. The fragment coding for the intron 1 of the mouse Tcf4 gene 
was then subcloned upstream of the firefly luciferase in the MluI/BglII sites of the pGL-3 basic 
vector. pGL3-Tcf4prom-ex1: The first exon and a part of the first intron of the mouse Tcf4 gene 
(+46/+1080) was amplified by PCR from Bl6 mouse kidney genomic DNA. The primers used for 
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this PCR reaction contained a BglII site in the forward primer (5´-GGA AGA TCT AAT GTA 
TCT TTC AGG GAA ACC T-3´) and MluI-BglII sites in the reverse primer (5´-TTT AGA TCT 
ACG CGT CAC CGA GCA CCT CAT TTT C-3´). The PCR product was first cloned into 
pGEM-T vector and verified by sequencing. The fragment was subcloned downstream of the 
mouse Tcf4 promoter gene in the BglII site of the PGL3-Tcf4prom vector. The MluI cassette 
containing Tcf4 promoter and first intron was further subcloned upstream of the Tcf4 intron 1, in 
the MluI site of the pGL-3 Tcf4intr vector to create the pGL3-Tcf4reg. pGL3-Tcf4prom rev: 
The same fragment as described for the pGL3-Tcf4prom was amplified by PCR from Bl6 mouse 
kidney genomic DNA. Both primers used for this PCR reaction were coupled with a BglII site. 
The PCR product was first cloned into pGEM-T (Promega) vector and subcloned into the BglII 
site of the pGL3-basic vector. pGL3-Tcf4intr1 rev: the fragment containing the DNA fragment 
coding for the intron 1 of Tcf4 gene was excised from the pGL3-Tcf4intr1 vector and subcloned 
into the MluI/HindIII sites of the pGEMZF(+) vector. The fragment was then subcloned in the 
KpnI/MluI sites of the PGL-3 basic vector. The reverse orientation of the DNA fragment coding 
for Tcf4 promoter and the first intron was confirmed by restriction mapping. pGL3-TK-
Tcf4intr1 – The DNA fragment coding for the Thymidine Kinase (TK)  promoter was amplified 
by PCR from Bl6 mouse kidney genomic DNA. Both primers used for this PCR reaction were 
coupled with KpnI restriction sites. Forward primer (5´- ATT GGT ACC GAG CTC CAC CGC 
GGT GGC GG-3´). Reverse primer (5´-TTT GGT ACC CTC GAG ATC TGC GGC AC -3´). 
The PCR product was first cloned into pJET1.2 vector and verified by sequencing. The fragment 
coding for the TK promoter was then subcloned upstream of the Tcf4 first intron in the KpNI site 
of the pGL3-Tcf4intr1 vector. 
II. Expression vectors 
The pRK7-FLAG vector was created by cloning the oligonucleotides AGC TTC TCG AGA 
TGG ACT ATA AGG ACG ATG ACG ATA AGG and AGA GCT CTA CCT GAT ATT CCT 
GCT ACT GCT ATT CCC TAG into the HindIII and BamHI digested pRK7 vector. These 
oligonucleotides encode for the short hydrophilic 8 amino acid (aa) peptide Asp-Tyr-Lys-Asp-
Asp-Asp-Asp-Lys. This epitope is likely to be located on the surface of a fusion protein due to its 
hydrophilic nature and, therefore, accessible to antibodies. The small size of the peptide limits 
interference with the fusion protein’s function and transportation. 
pRK7-GFP: The coding sequence of the enhanced green fluorescent protein (eGFP) was 
amplified by PCR using pEGFP-C1 vector (Clontech) as template. The primers used for this PCR 
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reaction included a BamHI site in the forward primer (5´- AAA GGA TCC ATG GTG AGC 
AAG GGC GAG GAG C-3´) and an EcoRI site in the reverse primer (5´-TTT GAA TTC CTT 
GTA CAG CTC GTC CAT GCC-3´). The PCR product was first cloned into pGEM-T vector and 
verified by sequencing. The eGFP was then subcloned in the BamHI/EcoRI sites of the PRK7 
vector.  
pRK7-Zac-eGFP: The coding sequence of the mouse Zac1 gene (NM_009538.2) including the 
start codon but not the stop codon, was amplified by PCR using  the pfu DNA polymerase and 
PRK-Flag Zac1 as template. The primers used for this PCR reaction were coupled with a BamHI 
sites in the forward primer (5´-GGA TCC ATG GCT CCA TTC CGC TGT CAA -3´) and in the 
reverse primer (5´-GGA TCC AAC TGT CCA TTT CTT ATA GAC GAG-3´). The PCR product 
was first cloned into pJET1.2 vector and verified by sequencing. The coding sequence of Zac1 
was then subcloned in frame upstream of the eGFP in the BamHI site of the PRK7-eGFP vector. 
The human TCF4-B (pCDNA3-ITF2B) and TCF4-A (pCDNA3-ITF2A) (Herbst et al., 2009a) 
expression vectors were kind gifts from Dr. Andreas Herbst (Department of Medicine II, 
University of Munich, Marchioninistrasse 15, 81377, Munich; Germany) and were used for 
recombinant proteins production and antibodies validation. The BamHI/XhoI (blunted) fragments 
encoding for the human TCF4-B or TCF4-A were subcloned into the BamHI/EcoRV sites of the 
pRK-Flag to generate the pRK-Flag-TCF4-B and pRK-Flag-TCF4-A respectively.  
The mouse Tcf4-B (PGK-mITF2B) and Tcf4-A (PGK-mITF2A) (Skerjanc et al., 1996), 
expression vectors were kind gifts from Dr. Ilona Skerjanc (Department of Biochemistry, 
Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa; Canada). 
The mouse flag-tagged Tcf4 expression vector (pCDEF3-Flag E2-2) (Tanaka et al., 2009) was a 
kind gift from Dr. Susumu Itoh (Department of Experimental Pathology, Graduate School of 
Comprehensive Human Sciences, University of Tsukuba, Tsukuba; Japan). These plasmids were 
used for antibodies validation.  
e) Recombinant protein construct 
GST-Tcf4-B (pGex2tk-TCF4-B) and GST-TCF4 total (pGex2tk-TCF4) plasmids were used to 
produce recombinant GST fused peptides. For prokaryotic expression, the human TCF4-B cDNA 
coding for the amino acid (aa 32-154) (isoform B specific) or coding for the amino acids (aa 418-
536) (present in both Tcf4 isoforms) were amplified by PCR using the pCDNA3-ITF2B 
expression vector as template. The primers used for this PCR reaction were coupled with a 
BamHI site in the forward primer (Total TCF4: 5´-ATT GGA TCC ATG CAT GGA ATC ATT 
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GGA CCT T-3´ / TCF4-B: 5´-CAT GGA TCC AGC AGT GGG AAA AAT GGA-3´ ) and an 
EcoRI site in the reverse primer (Total TCF4: 5´-ACC GAA TTC ATC TAA TTT CTT GTC 
CTC CGA-3´ / TCF4-B: 5´-TAC GAA TTC ATT ATT GCT AGA ATA CTG ATA-3´ ). The 
fragments were first cloned into the pJET1.2 vector (Thermo scientific) and subcloned into the 
BamHI/EcoRI sites of the pGex2tk (Pharmacia) vectors. All constructs used in this study were 
entirely sequence verified. 
e) Plasmid preparation 
I. Plasmid miniprep 
In order to screen positive recombinants, plasmid DNA was extracted from E.coli DH5α. 
Colonies were picked from an agar plate and incubated in 1.5 ml growth medium supplemented 
with ampicillin (200 µg/ml). Cultures were incubated 6-8 hours or overnight at 37 °C with 
vigorous shaking. 1 ml of each overnight culture was transferred in a 1.5 ml reaction tube. 
Bacteria were pelleted down using a bench-top centrifuge (1 min, 13000 g, RT). The cell pellet 
was resuspended in 200 µl TEG (25 mM Tris pH 8.0, 10 mM EDTA, 100 μg/ml RNAse A, 1% 
glucose) on shaking platform or vortexer, lysed by adding 200 μl alkaline SDS (200 mM NaOH, 
1% (w/v) SDS) and mixed immediately by inverting the tube for 6-8 times. After incubation at 
RT for 5 minutes, the reaction was stopped by adding 200 μl 3M KAc. The tube was inverted 
again for 6-8 times and then left on ice for 5 minutes and centrifuged (10 min, 13000 g, RT). The 
supernatant containing plasmid DNA was transferred into a new 1.5 ml reaction tube and mixed 
with 500 μl 2-propanol. The tube was then centrifuged (10 min, 13000 g, RT) to pellet the 
plasmid DNA. The pellet was washed with 70% ethanol and centrifuged (5 min, 13000 g, RT). 
The supernatant was carefully removed; the pellet was air-dried and dissolved in 10 μl TE (10 
mM Tris, 1 mM EDTA, pH 8). The plasmid DNA can be used immediately or stored in a -20 °C 
freezer. 
II. Plasmid maxiprep 
To obtain more than 100 μg of plasmid DNA, maxi-preparation of plasmid DNA was performed. 
Two days prior plasmid extraction, DH5α were transformed and selected on ampicillin-
supplemented agar plate. A single growing colony was picked up from the agar plate and 
resuspended in 4 ml of SOB medium (tryptone 20 μg/ml, yeast extract 5 μg/ml, NaCl 10 mM, 
KCl 2.5 mM) supplemented with ampicillin (200 µg/ml). After incubation overnight at 37 °C 
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with vigorous shaking, bacterial suspension was transferred in 500 ml flask containing 40 ml of 
TBA (tryptone, 12 μg/ml; yeast extract, 24 μg/ml; glycerol, 0.4%) and 10 ml of TBB (KH2PO4, 
0.17 M; K2HPO4, 0.72 M) supplemented with ampicillin (200 µg/ml). The culture was incubated 
overnight at 37°C with vigorous shaking. The plasmids were then purified using a NucleoBond® 
PC 100 kit (Macherey-Nagel). 
f) Cell culture and transfection experiments 
I. Cell cultures 
All cells were kept in a 5% CO2 humidified atmosphere at 37 °C.  
LLC-PK1 cells are an epithelial cell line (ATCC No. CL-101) originally derived from porcine 
(pig) kidneys. The cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin. In this study, LLC-
PK1 cells were used for reporter assay and for electroporation of pRK-Flag Zac1 and Tcf4 
expression vectors to validate Tcf4 antibodies. 
DLD1-ITF2 cell line is a kind gift from Dr. Andreas Herbst (Department of Medicine II, 
University of Munich, Marchioninistrasse 15, 81377, Munich; Germany) and is a stable clone 
overexpressing the human TCF4-B transgene under the control of a Tetracycline dependent 
promoter (Tet ON system). It was generated from the human colorectal adenocarcinoma cell line 
DLD1 (ATCC No. CL-101). Cells were grown in DMEM medium supplemented with 10 % FCS 
and penicillin/streptomycin. Expression of the transgene TCF4-B was induced for 48 hrs by 
adding doxycycline to the growing medium (1 µg/ml final concentration). This cell line was used 
for antibody validation.   
C17.2 (ECACC No 7062902) is an immortalized mouse neural progenitor cell line capable of 
differentiation in vitro and in vivo. The cell line was established by retroviral-mediated 
transduction of the avian myc oncogene into mitotic progenitor cells of neonatal mouse 
cerebellum. In this study, C17.2 cells were first used to create stable clones overexpressing Zac1 
under the control of a tetracycline dependent promoter –Tet OFF system- (C23_11 clone), to 
identify by microarray (24k mouse cDNA arrays - Max-Planck-Institute of Psychiatry, Munich; 
Germany) (Landgrebe et al., 2002) scanned on a Perkin-Elmer Life Sciences ScanArray 4000 
laser scanner genes whose expression was differentially regulated upon Zac1 overexpression. 
C17.2 cells were used then to validate Tcf4 as a direct target gene of Zac1. C17.2 cells were 
grown in DMEM supplemented with 10% FCS and penicillin/streptomycin. C23_11 were grown 
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in the same medium supplemented with 100 ng/ml tetracycline. To induce expression of Zac1 
transgene, cells were first rinsed once with PBS, before adding fresh growing medium 
tetracycline free. 
46C cell line is a mouse embryonic stem cell line growing as adherent monolayer which was 
generated by gene targeting of E14Tg2a (Aubert et al., 2003). The open reading frame of the 
early marker of neuroepithelial cells, Sox1 is replaced with the coding sequence of eGFP linked 
to a puromycin-resistant gene, that allows monitoring of neural differentiation. Cells were 
routinely propagated without feeders in Lif-supplemented GMEM medium containing 10% 
Knockout serum (KSR) and differentiated into neural cells by Lif-withdrawal and medium 
change as described previously (Ying and Smith, 2003). Differentiated cells were grown in a 
normal differentiation medium that consists in a mix 1:1 of DMEM-F12 and Neurobasal media to 
which 0.5 mM Glutamine, 0.05 mg/ml BSA, B27 serum replacement and N2 supplement 
(containing: human transferrin 1 mM, insulin recombinant full chain 500 mg/L, progesterone 2 
µM, putrescine 10 mM, selenite 3 µM) were added. For embryoid bodies formation, 46C cells 
were resuspended at 2x10
4
 cells/ ml in differentiation in suspension medium containing a mix 1:1 
GMEM medium supplemented with 10% Knockout serum (KSR)/ DMEM-F12 supplemented 
with 0.05 mg/ml BSA, 0,02 mM ß-mercaptoethanol and N2 supplement. Cells were grown in 
suspension in a 6-cm Petri dish for 4 days, with medium changed every second day. For retinoic 
acid treatment, cells were differentiated for 4 days in normal differentiation medium 
complemented with 0.1 µM of All-trans Retinoic Acid (Sigma Aldrich). 
Neurosphere (NS) cultures- At E15, pregnant mice were killed by cervical dislocation and uteri 
were withdrawn. Extra-embryonic tissues were removed and after opening the skull, brains were 
carefully extracted under a hood in sterile conditions. Each 3 brains were then cut into small 
pieces with thin sterilized scissors and they were transferred into a 1.5 ml reaction tube 
containing 1 ml of digestion medium containing a mix 1:1 accutase / 0.05 % trypsin 
supplemented with 100 U/ml DNase. Tubes were incubated 10 min at 37 °C on a shaking 
platform. Digestion reaction was stopped by transferring the tube content into a 15 ml tube 
containing 5 ml of DMEM-F12 supplemented with 10% FCS. Non digested tissue was finally 
dissociated mechanistically with a 10 ml plastic pipette. After a brief centrifugation at 70 g for 1 
min, the supernatant containing cell suspension was collected and transferred into a new tube. 
This process was repeated until the pellet disappeared. Tubes were then centrifuged at 800 g for 5 
min and cell pellets were resuspended into 1 ml of growing medium containing a mix 1:1 
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DMEM-F12 / Neurobasal to which 0.5 mM Glutamine, 0.05 mg/ml BSA, B27 serum 
replacement and N2 supplement were added. Cells were counted using a hemacytometer, and 
were seeded in uncoated T75 Flasks at 1x10
5 
cells/ml in growing medium supplemented with 10 
ng/ml EGF and FGF2 (final concentration) to allow cells to grow in suspension and to form 
aggregates after 1 day in culture. Medium was changed every second day, and NS were passaged 
after 5 days in culture. After the second passage, cells were seeded in differentiation medium at 
1x10
5
 cells/well in 6-well plates. The differentiation medium was renewed every second day. 
Neuronal differentiation was performed as described (Fath et al., 2009), briefly cells were seeded 
on PDL-coated plates, in Neurobasal-A medium to which N2 supplement, 0.5 mM glutamine and 
2.5 µM arabinofuranosyl cytidine (Ara-C) (Sigma Aldrich) were added. Astrocytic differentiation 
was induced by plating the cells on uncoated plate in a medium containing a mix 1:1 DMEM-F12 
/ Neurobasal medium to which 0.5 mM glutamine, 0.05 mg/ml BSA, B27 serum replacement, N2 
supplement, 1% of PANSera ES4 and 10
6
 U/ml of Lif were added.  
Neural precursors, primary hippocampal neurons and primary cerebellar neurons were 
dissected from brains of E15, P3 and P7 Cd1 mice respectively. Briefly, the region surrounding 
the lateral ventricle, the hippocampi and cerebelli were carefully dissected and all meninges and 
blood vessels were removed. Tissue was then sliced using a McIIwair tissue chopper and pieces 
were digested for 10 min with gentle shaking at 37 °C in 5 ml of EBBS supplemented with 
0.05% trypsin, 0.03 mg/ml BSA and 100 U/ml DNase. Digestion was stopped by adding 15 ml of 
Neurobasal A medium supplemented with 0.4 mg/ml Soy bean trypsin inhibitor, 3 mg/ml BSA, 
2% FCS (all final concentrations) and B27 serum replacement. After a brief centrifugation step at 
70g, the supernatant containing cells in suspension was filtered through a 30 µm nylon strainer 
and the undigested tissue was mechanistically dissociated using a BSA pre-coated pipette. This 
process was repeated until the pellet disappeared. Cells were pelleted at 200 g for 6 min and 
resuspended in 3 ml of Neurobasal-A medium supplemented with B27 serum replacement. The 
cell suspension was then layered on a BSA gradient and samples were centrifuged at 70g for 6 
min. Cells were resuspended in Neurobasal-A medium supplement with 0.5 mM glutamine, 0.1 
mM kanamycin and B27 serum replacement and plated at 5x10
4 
cells/well in 12-well plates and 
at 5x10
5
 cells/well in 6-well plates.   
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II. Transfection 
LLC-PK1 cells were seeded the day prior to electroporation at 1x10
7 
cells per 15-cm culture dish. 
Cells were harvested by trypsinization and resuspended in 1 ml electroporation buffer (1x EP 
buffer) (50 mM K2HPO4; 20 mM CH3KO2; 20 mM KOH). 50 μl of cell suspension was added to 
a 100 μl mixture containing different amount of pRK-Flag Zac1 or pCDEF3-Flag E2-2, 
pCDNA3-ITF2A, PGK-mITF2B, PGK-mITF2A, pCDNA3-ITF2B, 4 μl MgSO4, 20 μl 5 x EP 
buffer, 2 μg PAM vector DNA, and water. The mix DNA-cells was transferred into a 4 mm 
electroporation cuvette (Molecular Bioproducts) and left at room temperature for 10 minutes. 
DNA was electroporated into the cells by using a BTX 600 electroporator (290V, 500μF, 720Ω). 
After pulse delivery, the cells were immediately plated in a 10-cm culture dishes, and cultivated 
for 24 hrs.  
C17.2, SK-NM-C, DLD-1 cells were all transfected using Turbofect in vitro transfection reagent 
(Thermo Scientific) according to manufacturer´s instructions (details of methods and amount of 
transfected DNA will be detailed in results part). For Zac1 sh-RNA experiments, a pool of 5 
different MISSION
®
 shRNA Plasmid DNA targeting Zac1 (Sigma Aldrich) was transfected in 
C17.2 cells using Turbofect in vitro transfection reagent. The parent vector PLKO.1 was used as 
control. 
Clone Zac1 mRNA region targeted Sequence (5´-> 3´)
NM_009538.1-2608s1c1 3´UTR CCGGGACGCTATTGATGTCTCCATTCTCGAGAATGGAGACATCAATAGCGTCTTTTTG
NM_009538.1-1011s1c1 CDS CCGGCCACTGTGATAGATGCTTCTACTCGAGTAGAAGCATCTATCACAGTGGTTTTTG
NM_009538.1-1197s1c1 CDS CCGGCCAGAGCAATTTCCAACTCATCTCGAGATGAGTTGGAAATTGCTCTGGTTTTTG
NM_009538.1-1732s1c1 CDS CCGGCCAATTATTCTTCAGGAGCATCTCGAGATGCTCCTGAAGAATAATTGGTTTTTG
NM_009538.1-1198s1c1 CDS CCGGCAGAGCAATTTCCAACTCATTCTCGAGAATGAGTTGGAAATTGCTCTGTTTTTG  
Table 3: Clone Id number, and sequences of the sh-RNA used to knock down Zac1 expression 
Differentiating cells derived from neurospheres and 46C cells were transfected using 
lipofectamine 2000 reagent (Life technologies) according to manufacturer´s instructions. For 
luciferase assay, cells were seeded 48 hrs before transfection in a 12-well plate at 3x10
5
 
cells/well. In each well, 6 µl of lipofectamine 2000 reagent were added to 50 µl of OPTIMEM 
medium and mixed with 50 µl of OPTI-MEM medium containing 1 µg of luciferase reporter 
constructs, 0.5 µg pRK7-β-gal and increasing amounts of pRK-Flag Zac1 or pRK-Flag Zac1-
ZF7. After 20 minutes incubat-ion to allow DNA-Lipofectamine complexes to form, the mix was 
added to the well. 24 hrs after transfection, luciferase activity was measured. 
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Primary hippocampal and cerebellar neurons were nucleofected with different amounts of pRK7-
Zac1-GFP and pRK7-GFP using the Amaxa® Basic Neuron SCN Nucleofector® Kit and the 
Nucleofector™  technology (Lonza) [program SCN basic neuron 3]. After nucleofection, cells 
were seeded in 6-well plates at 5x10
5
 cells/well for RNA extraction and qRT-PCR, and in 12-
well plates at 1x10
5
 cells/well for immunocytochemistry. Gene expression analysis and 
immunocytochemistry were performed 3 days after transfection.   
g) Luciferase assay 
To measure promoter activity, cells were washed twice with PBS and then thoroughly lysed in 
100 μl lysis buffer (75mM Tris-HCl, 10mM MgCl2, 1% Triton X-100, 2mM ATP, 1 mM DTT). 
50 μl of aliquots were measured in a LKB luminometer for 20 seconds. As an internal control of 
transfection efficiency, the luciferase readings were normalized on β-galactosidase activity from 
a cotransfected expression vector (pRK7-β-gal) (Hoffmann et al., 2003). The β-gal activity in the 
extracts was measured as described previously (Spengler et al., 1993).  
h) Protein preparation 
I. Protein concentration and purity 
Bradford assays were used to determine the concentration of all proteins used in this study. The 
concentrated assay buffer was first diluted 1:5 and standards were prepared containing a range of 
20 to 200 μg protein (BSA) to a standard volume. The samples were diluted (2 μl in 200 μl water) 
to an estimated concentration of 20 to 200 μg/ml. 800 μl Bradford assay was added to each 
sample and protein standards, and the absorbance was measured at 590nm. Protein concentrations 
of samples were deduced from the standard curve. Coomasie blue staining was then further used 
to assess the purity, the integrity of recombinant protein preparations and the rough quantity. 
Proteins were separated by electrophoresis on a 10 % polyacrylamide gel. Size markers and BSA 
standards (50, 250, 1000 ng) were included. Proteins were separated by applying 100 V to the 
gel. The gel was then soaked in 0.2% Coomassie blue for 1h and destained in 40% methanol, 
50% acetic acid solution overnight. The gel was then blotted on to paper and dried. 
II. Recombinant proteins 
Recombinant GST-TCF4 fusion proteins were used to produce anti-sera after injection in rabbits. 
After transformation of DH5α bacteria with pGEX-2TK-TCF4 vectors, single colonies were 
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grown at 37 °C in 50 ml 2YT (0.16 % tryptone, 0.1 % yeast extract, 0.1 % NaCl) overnight, to 
which 450 ml 2YT were added, and bacteria were grown at 37 °C until sufficient cell density was 
reached, indicated by an OD600 of 0.5-1.0. Production of fusion proteins was then induced by 
adding 1 mM IPTG to the cultures which were incubated for 2 hours at 30 °C. The GST-proteins 
were purified using glutathione-sepharose beads (Hoffmann et al., 2003) and purity after elution 
was assessed by Coomasie blue staining.  
i) Antibody production  
500 µg of GST fusion proteins (GST-TCF4-B and GST-TCF4) were sent to PINEDA 
Antikörper-Service (Berlin) as antigens to immunize rabbits against the mouse TCF4-B protein 
and the 2 mouse protein isoforms of TCF4. On the first day of immunisation, animals received an 
intradermal injection of the GST fusion protein completed with Freund´s complete adjuvant to 
enhance immune response. Later, animals were subcutaneously injected with the antigen solution 
and Freund´s incomplete adjuvant (day 20, 30, 40, 60). At day 60, immunoreactivity of the 
antisera was verified by western blot. In case of insufficient immunoreactivity, animals received 
one more injection of antigen solution and Freund´s incomplete adjuvant at day 75 and serum 
was extracted at day 90. Once validated by western blot, antisera were tested for further 
applications (Immunocytochemistry, immunohistochemistry and chromatin immunoprecipitation) 
and their optimal conservation conditions were determined.  
j) Western blots 
Cells were seeded in 10 cm or 6-well plate 24 hours before harvesting. The cells were first 
washed twice with cold PBS, and then scrapped in 0.2 to 0.5 ml TE buffer supplemented with a 
protease inhibitor cocktail (PIC). Cells were disrupted by passing the homogenate several times 
through a hypodermic syringe (29G). An aliquot of 2 μl was kept at this step for measuring 
protein concentration by Bradford assay. Proteins were then denatured by adding 4X Laemmli 
buffer (200 mM Tris-HCl pH 6.8, 8 % SDS, 40 % glycerol, 0.4 % Bromophenol blue, 0.1 % β-
mercaptoethanol) and incubating the mix at 95 °C for 5 minutes. Samples were stored at -20 °C 
until use. Equivalent amounts of protein (10 to 100 μg) were subjected to electrophoresis on an 
SDS-PAGE 8 % polyacrylamide gel. The gel was then blotted onto a nitrocellulose membrane, 
and equal loading of protein in each lane was assessed by brief staining of the blot with Ponceau 
red. To prevent antibody unspecific binding, membranes were blocked for 1 hr in (10 mM Tris, 
0.5 mM NaCl, 0.25% Tween, 4% (w/v) Slim Fast powder, pH 7) and incubated overnight at 4 °C 
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with primary antibodies diluted in the blocking solution. Membranes were washed 3 X 5 min in 
(10 mM Tris, 0.5 mM NaCl, 0.1% Tween, 4%, pH 7) and incubated for 1 h at room temperature 
with HRP conjugated anti-rabbit (1/4000), mouse (1/2000) or guinea pig (1/4000) antibodies 
(Sigma-Aldrich) , diluted in blocking solution. Specific reactions were revealed with the ECL 
Western blotting detection reagent (GE healthcare). The first film was exposed for 30 second to 
check signal appearance and then exposure time was adjusted to the strength of the signal. 
k) Immunohistochemistry 
I. Fixation of mouse brains and cryosections 
Prior to cutting cryosections from embryonic and postnatal mouse brains, the tissue was fixed 
overnight at 4 °C in 4  % PFA in PBS, rinsed with PBS and placed overnight in 20% sucrose/PBS 
at 4 °C. Then, the brain or head was embedded in Tissue Tek, frozen and cut into 10 µM 
cryosections. Sections were collected on SuperFrost microscope slides and stored at -20 °C. 
II. Immunocytochemistry (ICC) / Immunohistochemistry (IHC) 
Cells were seeded on coverslips in 12-well plates, fixed with pre-warmed 4% paraformaldehyde
 
in PBS containing 2% sucrose for 5 minutes at 37 °C and rinsed with PBS. Frozen brain sections 
were allowed to warm-up slowly at room temperature for 30 min before washing them twice with 
PBS. The same protocol was then applied to both coverslips and brain sections. 
Coverslips were incubated 2 hours with blocking solution (5 % BSA, 5% normal goat serum, 
0.05% Triton X-100, 50 mM Tris-HCl, 50 mM NaCl, pH 7.4). Coverslips were then incubated 
with the primary antibodies diluted in blocking solution overnight in a humidifying chamber at 4 
°C. Coverslips were then washed three times
 
with PBS for 10 minutes and incubated at room 
temperature for 2 hrs with secondary antibodies diluted
 
in blocking solution (1/1000). Coverslips 
were washed with PBS three times for 10 minutes prior addition of 4′,6-Diamidin-2-phenylindol 
(DAPI) diluted in PBS (1/6000) for 5 minutes. Finally, coverslips were washed with PBS three 
times for 10 minutes before mounting in Mowiol on SuperFrost microscope slides. Confocal 
images were taken using an Olympus laser scanning confocal microscope. Phase-contrast and 
fluorescence images were taken using an Olympus BX61 microscope equipped with a F-view II 
digital camera.  
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f) Chromatin immunoprecipitation (ChIP) 
ChIP experiments were performed in vitro and in vivo to investigate the binding of Zac1 and Tcf4 at 
several gene loci. For in vivo ChIP, frozen tissues were stored at -80 °C in 1.5 ml tubes. First, tissue 
was crushed using a pestle and resuspended into 300 µl of ice-cold PBS containing a protease 
inhibitor cocktail (PIC) (Sigma Aldrich). The homogenate was then further passed several times 
through a hypodermic syringe (29G). Tubes were then incubated 15 min at room temperature on a 
rotating platform in presence of 1 % formaldehyde to cross-link proteins with DNA. Excessive 
formaldehyde was quenched by adding glycine (final concentration of 125 mM). Pellets were washed 
twice in ice-cold PBS containing PIC, by successive centrifugation steps (5 min at 800 g, 4°C). 
Samples were then processed according to the Upstate Biotechnology ChIP Kit (Magna ChIP G, 
Millipore) protocol with the following modifications: Samples were sonicated 3 times for 5 minutes 
using the BioruptorTM from Diagenode (cycles of: 30 seconds "ON" / 30 seconds "OFF") in a wet ice 
bath. After sonication, 5 μl of the sheared material was loaded on a 1 % agarose gel to check the 
fragment sizes. The DNA smear on the gel sould range between 200 bp and 1000 bp. DNA 
concentration in the sheared chromatin was determined with a SmartSpec Plus spectrophotometer 
(Bio-Rad). The chromatin samples were either subjected to immunoprecipitation or stored at -80 °C 
until further use. 1 OD260nm chromatin DNA was then subjected to immunoprecipitation using Zac1 
LPR rabbit antibody (1/100) or Tcf4 total rabbit antibody (1/50). To reduce unspecific binding during 
immunoprecipitations, antibodies were pre-incubated with sheared chromatin DNA on a rotating 
platform at 4 °C overnight, while Dynabeads Protein G (Invitrogen) were added in the following day 
and incubated for 1 hour at 4°C on a rotating platform. After reverse crosslinking, protein digestion, 
and DNA isolation using the UltraClean PCR Clean-Up Kit (Mobio), fragments were dissolved in 
100 μl TE buffer and subjected to standard or real-time PCR. 
For in vitro ChIP, samples were processed according to the protocol described here above with the 
following modifications: samples were sonicated three times for 3 minutes and 5 OD260nm chromatin 
DNA was subjected to immunoprecipitation. 
l) Statistical analysis and computer software 
Transcriptional factor binding sites analysis were performed using Genomatix software. Primers were 
designed according to the general guidelines by the software Oligo 6. Fluorescent images were 
analyzed using Fluoview FV10-ASW software. Cells were counted manually using Image J software. 
Graphs and statistical analysis were performed using Microsoft Excel software, pictures and figures 
were created using Excel, PowerPoint and Corel Draw.   
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To identify Zac1 target genes that could underlie its function in neural progenitors, we performed 
gene expression analysis in the immortalized neural stem cell line C17.2 (Lynch et al., 1996). 
This cell line can be routinely maintained as neural progenitors in standard cell culture conditions 
and can be transfected with high efficiency. The C17.2 (ECACC No 7062902) cell line is an 
immortalized mouse neural progenitor cell line capable of differentiation in vitro. The cell line 
was established by retroviral-mediated transduction of the avian myc oncogene into mitotic 
progenitor cells of neonatal mouse cerebellum. We generated a panel of inducible C17.2 Zac1 
clones using a Tet-off system (Hoffmann et al., 1997). By cultivating cells in absence or presence 
of tetracycline, ectopic Zac1 expression was switched on and off respectively. The clone C23_11 
was selected because of its maximal Zac1 induction (approximately 2 fold) and because ectopic 
Zac1 expression lead to a strong growth inhibition. As expected from a cell cycle regulator gene, 
induction of Zac1 lead to a 70 % growth inhibition after 8 days in culture,  (Fig. 6 - by the 
courtesy of Udo Schmidt-Edelkraut).  
 
 
Figure 6: Induced Zac1 expression in C23_11 clone inhibits cell proliferation. Cells were seeded at 2000 
cells/well of a 24-well plate, cultivated in the presence or absence of tetracycline (+Tet/-Tet conditions) and cell 
numbers were measured daily with a particle counter Z1 (Coulter). Medium was renewed every 2nd day. Points, 
mean of three independent experiments; bars, standard deviation (SD). 
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I. Zac1 induces expression of Tcf4 in the neural stem cell line C17.2. 
Using cDNA microarrays, a comparative genome-wide expression analysis of the inducible Zac1 
clone cultivated for 8, 16, and 24 hours with or without tetracycline was performed. Only genes 
exhibiting a >1.5-fold difference between tetracycline-positive and tetracycline-negative 
conditions were considered. Collectively, Zac1 induction differentially affected 127 common 
genes (data not shown); belonging to different functional groups, including metabolism, 
transcription, proliferation, signaling/transport, and cell structure.  
Among these differentially regulated with known function during brain development was the 
isoform B of the Tcf4 (E2-2/ITF2/SEF-2) gene, exhibiting a 1.7-fold activation. We validated 
Tcf4 up-regulation following Zac1 induction by quantitative RT-PCR (qRT-PCR) analysis which 
revealed a 1.5-fold increase in Tcf4 mRNA. Finally, a time course analysis revealed a transient 
increase in Zac1 induction peaking at 9 hrs and normalizing at 24 hrs after tetracycline removal, 
which was mirrored by Tcf4 gene expression, thus supporting the idea of direct regulation of Tcf4 
gene expression by Zac1 (Fig. 7).  
 
Figure 7: Induced Zac1 expression in C23_11 clone increases Tcf4 gene expression at different time points 
after tetracycline removal. Bars represent the induction in gene expression determined by qRT-PCR, normalized to 
control conditions in presence of tetracycline, and to the house keeping gene Mas. Bars represent the mean of 3 
independent experiments performed in duplicates, SD is shown.  
Results 
 
43 
 
The direct transactivation mechanism was confirmed by transfecting wild type (WT) Zac1 
construct in the parental cell line C17.2, which led to an increase in both Tcf4-B gene expression 
and protein levels.(Fig. 8.A-B). 
There are 2 known protein isoforms of TCF4, namely TCF4-A and TCF4-B, with both sharing an 
identical C-terminal part and having a distinct N-terminal part. TCF4-B the longest and best 
characterized isoform, possesses an extra transactivation domain (Herbst and Kolligs, 2008) and 
can act both as a transactivator (Pscherer et al., 1996; Persson et al., 2000a; Muir et al., 2006; 
Herbst et al., 2009a) and a repressor (Skerjanc et al., 1996; Chen and Lim, 1997; Lu et al., 2005). 
TCF4-A has weaker transactivation capacity and its function is less well understood (Herbst et 
al., 2009b; Sobrado et al., 2009). In order to determine if only one or the two isoforms were 
regulated by Zac1, we performed qRT-PCR analysis using isoform-specific primers, which 
revealed that Zac1 regulates specifically the expression of the Tcf4-B variant (Fig. 8.A). Beyond 
this point in this thesis, if not stated otherwise, Tcf4 will refer exclusively to Tcf4-B gene.     
  
 
Figure 8: Zac1 regulates Tcf4-B gene expression. A) qRT-PCR analysis revealing that Tcf4-B gene expression 
increases in a Zac1-dependent manner in C17.2 cells transfected for 24 hrs with increasing amount of pRK-Flag-
Zac1. Bars represent the mean of 4 independent experiments; SD is shown.*p<0.05, **p<0.01 (t-test). B) TCF4-B 
protein levels in C17.2 cells are increased after transfection with 100 ng of pRK-Flag-Zac1 as revealed by 
immunoblot - 50 µg of whole cell extract (WCE) were blotted. 
To determine if Zac1 can act as transactivator or coactivator of Tcf4 gene expression, we next 
transfected C17.2 cells with either the DNA-binding defective mutant form (Zac1 ZF7mt) or the 
Tcf4-B 
Zac1 
ß-Actin 
Mock     Zac1 
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transactivation domain deleted mutant form (Zac1 ΔLPR) (Hoffmann et al., 2003). Quantitative 
RT-PCR and immunoblot analysis revealed that in contrast to WT, Zac1 ΔLPR overexpression 
did not affect Tcf4 expression, while Zac1 ZF7mt induced Tcf4 at reduced levels (Fig. 9.A-B). 
Since deletion of the LPR domain does not impair the coactivator function of Zac1 (Hoffmann 
and Spengler, 2008) but abolished completely the induction of Tcf4 by Zac1, we conclude that 
Zac1 is not a coactivator of Tcf4 gene expression. In addition, its induction by Zac1 requires an 
intact Zac1 DNA-binding domain, indicating that Zac1 needs to bind to DNA to induce the Tcf4 
gene expression. These effects were not due to quantitative differences in expression of the 
different Zac1 constructs, as immunoblot analysis showed that all of them were expressed at 
similar level (Fig. 9.B).    
 
Figure 9:  Zac1 act as a transactivator of the Tcf4 gene. A) C17.2 cells were transfected with 100 ng of different 
Zac1 constructs (WT, ZF7 and ΔLPR) and Tcf4 gene expression was measured by qRT-PCR 24 hrs after transfection 
and normalized to mock transfected conditions (100%) and to the expression of the house keeping gene Mas. DNA 
binding or transactivation domain deficient mutants cannot induce Tcf4 expression ruling out coactivation 
mechanism of Tcf4 by Zac1. Bars represent the mean of 2 independent experiments ran in duplicates; SD is shown 
B) Protein levels of Tcf4 and Zac1 mutants were assessed by immunoblot – 50 µg of whole cell extract (WCE) were 
loaded; Zac1 constructs were expressed at similar levels, whereas Tcf4 protein level is increased only when the DNA 
binding domain and transactivation domains of Zac1 is intact. * Due to the deletion of the linker proline rich domain, 
the Zac1 mutant ΔLPR proteins migrate to lower molecular weight (~ 70 kda) compared to WT and ZF7 (~130 kda).    
Computational analysis, using the genomatix software, revealed Zac1 putative potential binding 
sites at Tcf4 promoter and first intron whereas no putative binding sites could be identified on the 
promoter of the isoform A of TCF4 (Fig. 10.A). ChIP analysis showed that Zac1 occupies 
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specifically the Tcf4 proximal promoter and the first intron, supporting a direct transactivation 
mechanism (Fig. 10.B).  
 
 
 
Figure 10: Zac1 occupies Tcf4 promoter and first intron in C17.2 cells. A) Schematic representation of Tcf4 
promoter and first intron; black boxes represent the 2 first exons (2 alternative exons I and the exon II); putative 
binding Zac1 sites are pictured as triangles and grey or black circles, numbers indicate their distance in base pair to 
the transcriptional start site (TSS or +1). Black bars indicate the genomic regions amplified by the primers used for 
ChIP experiment. B) ChIP experiments revealed Zac1 occupancy at Tcf4 proximal promoter and at elements in the 
first intron, but not on the promoter of the isoform A (Iso A). Values were first calculated as % of input, to which 
negative control (IgG) values were subtracted. Bars represent the mean of 3 independent experiments with 
duplicates; SD is shown.     
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Altogether these findings suggest that Tcf4 is a direct Zac1 target in the mouse C17.2 cell line 
and that transactivation might be mediated via the Zac1 binding sites in the proximal promoter 
and/or in the first intron. 
 
II. Zac1 regulates Tcf4 gene during neuronal differentiation of mouse 
embryonic stem cells. 
To study the precise molecular regulation of Tcf4 gene by Zac1 during neurogenesis, we used a 
well-characterized in vitro model of differentiation: the neuronal differentiation of the mouse 46C 
mES cell line. Hoffmann and Spengler (Hoffmann and Spengler, 2008), previously showed that 
Zac1 expression is up-regulated during early neuronal differentiation of the mouse embryonic 
stem cell line 46C. This is mimicking the transient increase in Zac1 expression observed in 
neuroepithelial cells and in neuronal progenitors in vitro and in vivo (Valente et al., 2005; 
Elkabetz et al., 2008; Abranches et al., 2009; Koch et al., 2009). We thus assessed next, whether 
Zac1 regulates the expression of the proneural factor Tcf4 during early neurogenesis. 
Upon Leukemia inhibitory factor (Lif) withdrawal from the medium, 46C cell colonies flattened 
and spread to give rise to single cells that acquired progressively neuronal morphology within 3 
days. During differentiation, the expression of the neural progenitor cell marker Nestin (Fig. 
11.B) and late neuronal differentiation marker TuJ-1 (Fig. 11.C) increased. In contrast, the 
expression of the pluripotency marker Oct4 decreased (Fig. 11.D). This indicates that the cells 
lost their pluripotency and acquired a neuronal fate. Interestingly, Zac1 and Tcf4 gene expression 
and protein levels were strongly up-regulated after 6 days of Lif withdrawal, suggesting that both 
genes might play a role during neuronal differentiation or have specific functions in immature 
neurons (Fig. 11.E-F).   
 
B 
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Figure 11: Zac1 and Tcf4 genes are upregulated during neuronal differentiation of the mouse embryonic stem 
cell line 46C. A) Light microscopy of mES cells which progressively differentiate into neurons following Lif 
withdrawal for the indicated number of days. B-C) The expression of the neural stem/progenitor marker Nestin (B) 
and of the late neuronal marker Tuj1 (C) increase during neuronal differentiation as revealed by RT-PCR and qRT-
PCR analysis. D) qRT-PCR analysis of the expression of the pluripotency marker Oct4, which is rapidly 
downregulated in mES cells upon Lif withdrawal. E) The expression of Zac1 and Tcf4 was measured following Lif 
withdrawal for the indicated number of days. Zac1 and Tcf4 are co-induced by Lif withdrawal. (F) Immunoblot 
analysis of 100 µg of WCE from mES cells grown for the indicated number of days in the absence of Lif. The 
coinduction of Tcf4 and Zac1 mRNAs translates into their increased protein expression. Bars represent the average of 
3 independent experiments ran in duplicates; SD is shown.  
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Two established protocols of neuronal differentiation, namely the embryoid formation (EB) 
(Watanabe et al., 2005; Kamiya et al., 2011) and treatment with retinoic acid (RA) (Guan et al., 
2001) were applied to the mES cells to confirm that Zac1 and Tcf4 were co-induced during 
neuronal differentiation of the 46C cells. Both protocols potently induced neuronal differentiation 
of the mES as indicated by the loss of Oct4 expression and by the strong up-regulation of the 
neural progenitor marker Nestin and neuronal markers N-Cadherin and TuJ-1 (Fig. 12.A). All 
treatments were associated with a fast and strong up-regulation of Zac1 and Tcf4 gene expression 
and protein levels during neuronal differentiation (Fig. 12.B-C).  
We further confirmed that Tcf4 is a Zac1 target gene by transfecting Zac1 in 46C cells, and could 
show that endogenous Tcf4 gene expression increased in a Zac1 dose-dependent manner (Fig. 
13).  
 
 
Figure 12: Zac1 and Tcf4 genes are co-induced during neuronal differentiation of mES. A) RT-PCR analysis 
showing that embryoid formation (EB) and all-trans retinoic acid (RA) treatment (0.1 µM) for 4 days induced 
neuronal differentiation of mES. The expression of the neural stem/progenitor marker Nestin and of the neuronal 
markers N-Cadherin and Tuj1 were increased after treatment in contrast to the expression of the stem cell marker 
Oct4. B) qRT-PCR analysis showing co-induction of Zac1 and Tcf4 expression during neuronal differentiation 
induced by EB or RA treatments. C) Immunoblot analysis of 100 µg of WCE from mES cells in presence of Lif and 
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after EB and RA treatments. The co-induction of Tcf4 and Zac1 mRNAs translates into their increased protein 
expression. Bars represent the mean of 2 independent experiments ran in duplicates; SD is shown. 
 
 
Figure 13: Zac1 regulates Tcf4 gene expression in mES cells (46C). qRT-PCR analysis revealing that Tcf4 gene 
expression increases in a Zac1-dependent manner in 46C cells transfected for 24 hrs with increasing amount of pRK-
Flag-Zac1 . Bars represent the average of 3 independent experiments ran in duplicates; SD is shown. The asterisk 
indicates significant difference (p<0.05,*) 
 
To identify Zac1 binding site(s) mediating Tcf4 expression, ChIP assays in undifferentiated cells 
and during neuronal differentiation were carried out and revealed multiple Zac1 binding sites on 
the Tcf4 promoter and first intron. Indeed, Zac1 binding was barely detectable in undifferentiated 
cells, whereas the withdrawal of Lif caused a marked increase in Zac1 occupancy at the Tcf4 
locus. Zac1 binding was restricted to the proximal promoter region (-485 and -89 bp) and to a 
region containing a 2 palindromic and two direct repeat elements located in the center of the first 
intron (+1933 bp) of the Tcf4 gene (Fig. 14). The concomitant increase in Zac1 binding to Tcf4 
and the increase in Zac1 and Tcf4 gene expression during neuronal differentiation, suggests that 
Zac1 might regulate Tcf4 by associating with its proximal promoter and first intron. 
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Figure 14:  Zac1 occupies Tcf4 proximal promoter and first intron during neuronal differentiation of mES 
cells. ChIP assays were conducted in the presence (ES) or absence of Lif for 3 (d3) or 6 (d6) days. In the presence of 
Lif, Zac1 binding is barely detectable at the Tcf4 locus, whereas strong association between Zac1 and Tcf4 proximal 
promoter and first intron (+1933) was detected upon Lif withdrawal. Values were first calculated as % of input, to 
which negative control (IgG) values were subtracted. Bars represent the average of 3 independent experiments ran in 
duplicates; SD is shown. 
To assess the contribution of each potential binding sites to Zac1-mediated Tcf4 gene regulation, 
different fragments encoding either the Tcf4 proximal promoter or Tcf4 first intron separately, or 
in conjunction, were cloned upstream of a luciferase reporter gene (Fig. 15 and Fig. 16.A). 
Luciferase assays were performed in undifferentiated cells. Each fragment met promoter criteria 
as they exhibit transcriptional activity, with the proximal promoter showing the highest activity. 
Inverting the orientation of each fragment (3´ to 5´) upstream of the luciferase reporter gene led 
to a strong decrease (50 to 100 fold) in promoter activity (Fig. 15).  
 
Interestingly, while the activity of the promoter or the first intron separately was not affected by 
Zac1 overexpression, the activity of the cassette coding for both promoter and first intron of Tcf4 
was induced up to 4 fold. This induction was impaired when the DNA binding defective mutant 
Zac1ZF7 was transfected (1.4 fold induction) (Fig. 16.B), hinting to the specific requirement of 
Zac1 to bind DNA in order to transactivate Tcf4. Altogether we suggest that Zac1 regulates Tcf4 
gene transcription by a coordinated binding to the proximal promoter and to an element located in 
the first intron. 
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Figure 15: Transcriptional activities of Tcf4 promoter, first intron and association of the promoter with the 
first intron. 46C cells were transfected with 250 ng of the ß-gal reporter gene, along with 500 ng of pGL3-basic or 
various PGL-3 Tcf4 fragments (Promoter: -887/+46 bp; Intron: +1087/+2754 bp; Promoter + Intron: -887/+2754 bp)    
inserted in the sense orientation (5´-3´; black bars) or in the reverse orientation (3´-5´; white bars), upstream of the 
luciferase firefly reporter gene. Luciferase activity of the transfected cell extracts were determined 24 hrs after 
transfection, normalized to ß-gal activity values and plotted on a logarithmic scale. Each fragment exhibits promoter 
activity which was strongly reduced when they were inserted in the reverse orientation. This suggests that each 
element can function as promoter. Bars represent the average of 2 independent experiments ran in duplicates; SD is 
shown.  
 
We asked next if the first intron of Tcf4 was a Zac1 responsive element that could enhance 
transcription in presence of a heterologous promoter containing Zac1 binding sites. To address 
this, Tcf4 first intron was cloned downstream of the TK promoter. Besides an increase in basal 
promoter activity caused by the promoter activity of the intron, Zac1 overexpression did not 
change promoter activity of the heterologous construct (Fig. 17). Similar results were obtained 
when the intron was cloned downstream of the SV40 promoter (data not shown). This suggests 
that the presence of both Tcf4 proximal promoter and intron is required for the Zac1-mediated 
regulation. This was further confirmed by inverting the orientation of the intron in association 
with the promoter, which abolished completely the Zac1-induced transcriptional activity.    
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Figure 16: Zac1 activates Tcf4 gene expression by regulating both promoter and intron transcriptional 
activity. A) Schematic representation of the Tcf4 promoter and first intron element cloned upstream of a luciferase 
reporter gene. Black boxes represent the 2 first exons (2 alternative exon I and the exon II); putative binding Zac1 
sites are pictured as triangles and grey or black circles. Numbers indicate the distance in base pair to the TSS (+1). 
Black bars indicate validated Zac1 binding sites at the Tcf4 locus, as revealed by ChIP. B) 46C cells were transfected 
with 250 ng of the ß-gal reporter gene, along with Mock (M) or increasing amount of pRK7-Zac1WT (white bars) or 
Zac1ZF7 (grey bars) and with 500 ng of PGL-3-Tcf4 fragments. Zac1 transfection increased promoter activity only 
when Tcf4 promoter and first intron were together and this activation depends on Zac1 DNA binding. Luciferase 
activity of the transfected cell extracts was determined 24 hrs after transfection and normalized to ß-gal activity 
values and to the mock transfected activity. Bars represent the mean of 4 independent experiments ran in duplicates; 
SD is shown. (*) p<0.05; (**) p<0.01 (t-test). 
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Figure 17: Tcf4 first intron does not act as enhancer of transcription. 46C cells were transfected with 250 ng of 
the ß-gal reporter gene, 100 ng pRK7-Flag Zac1 and with 500 ng of PGL-3-Tcf4 or PGL3-TK fragments. Tcf4 first 
intron does not act as a general Zac1-responsive element, and its promoter activity depends on the presence of the 
naïve Tcf4 promoter.  Luciferase activity of the transfected cell extracts was determined and normalized to ß-gal 
activity values and to the mock transfected activity Bars represent the average of 3 independent experiments ran in 
duplicates; SD is shown. 
 
III. Zac1 regulates Tcf4 expression during embryonic neurogenesis. 
As Zac1 regulates Tcf4 expression during early neural differentiation of mES, we asked next 
whether this regulation also occurs at later developmental stages after the onset of neurogenesis 
onset. To address this in vitro, we performed neurosphere culture from E15 mouse brains. 
Neurospheres (NS) are spheroid structures grown in suspension and in high concentration of EGF 
and FGF-2. NS consist of a heterogeneous mix of neural stem cells, neural progenitors and more 
differentiated cells with a rich extra-cellular matrix surrounding them. Once dissociated and 
seeded on PDL-coated dish, NS-derived cells show the capacity for self-renewal, Nestin 
immunoreactivity and the ability to differentiate into neurons, astrocytes and oligodendrocytes 
(Rao, 2004; Ahmed, 2009). NS were generated from whole embryonic brains and passaged twice 
every 5 days, with medium change each second day. At the third passage, cells were seeded on 
PDL-coated plate and grown as monolayer in presence of EGF and FGF-2. After 2 days in 
culture, the cell population was composed mainly of Nestin positive radial glial-like cells, that 
co-expressed Zac1 and Tcf4 (Fig. 18.A-C). Cells were then cultured in different conditions to 
Results 
 
54 
 
enhance neuronal or astroglial differentiation (see material and methods for detailed protocols) 
(Fig. 18.A). As observed during differentiation of mES, Zac1 expression was induced during 
differentiation of NSC supporting the idea that Zac1 is induced during general differentiation of 
progenitor cells (Alam et al., 2005; Valente et al., 2005). Indeed after 6 days of differentiation, 
Zac1 was up-regulated both in neurons and astrocytes; in contrast to the neurogenic factor Tcf4, 
which was restricted to neurons (Fig. 18.B) where it was highly expressed (Fig. 19).  
Reporter assays and ChIP analysis confirmed that Tcf4 is a Zac1 target gene in NSC and in 
differentiated cells with the strongest transactivational effect of Zac1 observed in neurons (Fig. 
20). Interestingly Zac1 occupancy on Tcf4 promoter and first intron increased exclusively during 
neuronal differentiation, and this, despite an increase in Zac1 expression during both neuronal 
and astroglial differentiation. This indicates that Zac1 binding to Tcf4 locus might be cell-type 
specific and does not depend on endogenous Zac1 expression level. Hence, Zac1 might regulate 
Tcf4 gene expression specifically in NSC and during their differentiation into neurons but not 
into glial cells.   
 
 
Figure 18: Zac1 and Tcf4 are co-induced during neuronal differentiation of NSC A) Distribution of NSC 
(Nestin), glial (GFAP) and neuronal cells (TuJ-1) among NS derived cells, grown in NSC conditions or in 
differentiation medium for 6 days. TuJ-1, GFAP and Nestin negative cells were counted as N/D . Bars represent the 
percentage of cells expressing the fate specific marker, normalized to the total cell number (nuclei stained with 
DAPI). Cultures were performed twice, and cells numbers were measured in 4 separate fields. B) qRT-PCR analysis 
showing Zac1 expression is induced during neuronal or astroglial differentiation for 3 or 6 days (N3/A3 and N6/A6) , 
whereas Tcf4 is only induced during neuronal differentiation. Bars represent the average of 3 independent 
experiments in duplicates; data were normalized to NSC conditions and to Mas. SD is shown. 
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Figure 19: Zac1 and Tcf4 are co-expressed during neuronal differentiation of NSC. Immunocytochemistry of 
NSC in proliferating conditions (NSC) and after astroglial or neuronal differentiation for 6 days (Astrocyte d6 / 
Neuron d6). Zac1 and Tcf4 are co-expressed in mature neurons (TuJ-1 positive cells), and in NSC (Nestin positive 
cells). Zac1 is also expressed in mature astrocytes (GFAP positive cells) in contrast to the proneural factor Tcf4. 
Scale bar: 100 µM 
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Figure 20: Zac1 regulates Tcf4 expression in neural progenitors and differentiating neurons. A) NSC, 
Astrocytes or Neurons were transfected with 250 ng of the ß-gal reporter gene, along with Mock (M) or increasing 
amount of pRK7-Zac1WT and with 500 ng of PGL-3-Tcf4reg. Zac1 transfection increased promoter activity of Tcf4 
construct in all cell types, with the highest induction observed in neurons. Luciferase activity of the transfected cell 
extracts was determined 24 hrs after transfection and normalized to ß-gal activity values and to the mock transfected 
activity. Bars represent the average of 3 independent experiments with duplicates; SD is shown. B) ChIP assays were 
conducted in NSC, in astrocytes or in neurons (after 6-day culture in differentiation medium). Zac1 occupies Tcf4 
proximal promoter (-485 and -89 bp) and first intron (+1933) in the 3 lineages. The strongest binding was detected in 
neuronal cells, suggesting that Tcf4 locus is more accessible to Zac1 in neuronal cells compared to NSC and 
Astrocytes. Values were first calculated as % of input, to which negative control (IgG) values were subtracted. Bars 
represent the average of 3 independent experiments with duplicates; SD is shown. 
To confirm our findings in vivo, we co-stained coronal sections of E15 mice brains using Zac1 
and Tcf4 antibody and observed the co-localization of the two proteins in distinct cells of the VZ 
and SVZ of the lateral ventricles, hinting to a possible co-regulation between the 2 transcription 
factors (Fig. 21.A). However, the characterization of the cells co-expressing Zac1 and Tcf4 needs 
to be performed. ChIP analysis of brain punches of this region confirmed that Zac1 binds 
strongly to Tcf4 locus in vivo (Fig. 21.B) and validate Tcf4 as Zac1 target gene during 
neurogenesis. A second brain region where Zac1 and Tcf4 protein levels could not be detected 
(data not shown) surrounding the third ventricle was used as negative control for ChIP 
experiment. Finally, after dissection of brain regions of E15 mice containing roughly the VZ and 
SVZ of the lateral ventricles, as well as the developing cortex, dissociated cells were 
nucleofected with increasing amount of Zac1, which induced Tcf4 gene expression (Fig. 21.C). 
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Altogether, we show that Zac1 regulates Tcf4 expression in neural precursors and/or mature 
neurons during neurogenesis.   
 
Figure 21:  Zac1 regulates Tcf4 in progenitors of the VZ and SVZ of the lateral ventricles of E15 mice. A) Zac1 
and Tcf4 immunoreactivity patterns in the region surrounding the lateral ventricles in the embryonic mouse (E15) 
brain. 10 µM coronal sections were obtained and incubated with guinea pig anti mouse Zac1 antibody and rabbit anti 
mouse Tcf4 antibody. Zac1 and Tcf4 are co-expressed in the neurogenic area surrounding the lateral ventricle (VZ 
and SVZ, but not in the Intermediate zone (IZ)). Scale bar: 100 µm. B) ChIP analysis of Zac1 occupancy at Tcf4 
promoter in the regions surrounding the lateral ventricles or the 3
rd
 ventricle. Brain punches from 5 animals were 
pooled and used for 2 independent immunoprecipitations. Values were first normalized to the Input, and then 
calculated as fold enrichment (Zac1 antibody value divided by the IgG value). % of Input could not be used here as 
the value of the IgG differed between the 2 brain regions. C) qRT-PCR analysis revealing that Tcf4 gene expression 
increases in a Zac1-dependent manner in neural progenitor cells and/or neurons, dissected from lateral ventricule 
area in E15 embryos, and nucleofected with increasing amount of pRK-Zac1-GFP. Cells were harvested 48 hrs after 
nucleofection. Bars represent the average of 3 independent experiments performed in duplicates; SD is shown. (*) 
p<0.05 (t-test). 
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IV. Zac1, Tcf4 and p57kip2 are co-regulated during brain development 
Finally, we investigated the biological significance of the regulation of Tcf4 gene by Zac1. As 
Tcf4 can act as a transcription factor, we tested whether the control of the expression of Tcf4 by 
Zac1 can affect the transcription of Tcf4 target gene. We decided to focus on the paternally 
imprinted gene p57
kip2
 for 3 reasons. 
1) It is co-regulated with Zac1 in the context of the Imprinted gene Network 
(Varrault et al., 2006).  
2) p57kip2 plays an important role in differentiation and migration of RGC and IPC 
during neurogenesis (Tury et al., 2011a).  
3) Zac1, Tcf4 and p57kip2 are known inducers of cell cycle arrest (Matsuoka et al., 
2006; Herbst et al., 2009a).    
p57
kip2 
is one of the three members of the the Cip/Kip family of cell cycle inhibitors. It is 
expressed in proliferating progenitors in the VZ and SVZ of the telencephalon, but also in 
cortical precursors and mature neurons. p57
kip2
 expression is strongly reduced in the adult brain, 
except in the developing cerebellum where it is transiently expressed during the postnatal 
cerebellar neurogenesis. p57
kip2
 has been identified as a functionally relevant target recruited by 
the E-proteins to induce cell cycle arrest in the human neuroblastoma cell line SK-N-SH 
(Rothschild et al., 2006). Hence, we first determined whether Tcf4 can regulate the expression of 
p57
kip2
 in the murine C17.2 cell line. To address this, cells were transfected with Tcf4 expression 
vector and endogenous p57
kip2 
gene expression was measured by qRT-PCR. Tcf4 overexpresssion 
induced p57
kip2
 by 1.5 fold confirming the role of Tcf4 as regulator of p57
kip2 
gene expression in 
the mouse brain (Fig. 22.C). Previous studies showed that p57
kip2 
might be directly regulated by 
Zac1; hence, it is difficult to determine the relative contribution of both transcription factors to 
p57
kip2
 gene regulation. However, in contrast to p57
kip2
, Zac1 gene expression was not affected by 
Tcf4 overexpression (Fig. 22.C), we could therefore conclude that Tcf4 could regulate p57
kip2
 
expression in a Zac1 independent manner. It is thus likely that both factors control the expression 
of the cell cycle regulator p57
kip2
. Additional Zac1 overexpression and knocking down 
approaches confirmed that the regulation of Zac1 expression mediates the expression of Tcf4 and 
of its target gene p57
kip2
 (Fig. 22.A-B-D).  
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Figure 22: Zac1 and Tcf4 regulate p57
kip2 
expression in C17.2 cells. A). Knock down of Zac1 by transfection of 
500 ng of a pool of shRNA targeted against Zac1 (shRNA-Zac1) for 24 hrs, resulted into a significant decrease of 
Zac1 and Tcf4-B mRNA levels as measured by qRT-PCR. B) Immunoblot analysis of 50 µg of WCE from C17.2 
cells transfected with 500 ng of scramble shRNA or shRNA-Zac1. The reduction of Tcf4 and Zac1 mRNAs after 
Zac1-knockdown translates into their increased protein expression. C) C17.2 cells were transfected for 24 hrs with 
100 ng of pCDEF3-Flag-Tcf4, and expression of Zac1 and p57
kip2
 was assessed by qRT-PCR. Overexpression of 
Tcf4 increased p57
kip2 
gene expression independently of Zac1. D) Knock down of Zac1 by transfection of 500 ng of a 
pool of shRNA targeted against Zac1 (shRNA-Zac1) for 24 hrs, resulted into a significant decrease of p57
kip2 
mRNA 
levels as measured by qRT-PCR. This indicates that regulation of Zac1 expression control Tcf4 and its target gene 
p57
kip2
 expression. Bars represent the average of 3 independent experiments ran in duplicates; SD is shown. *p<0.05; 
**p<0.01 (t-test).  
   
Finally, to verify these findings in vivo, we measured Tcf4 occupancy at p57
kip2
 promoter in two 
brain regions where they are both expressed (Alam et al., 2005; Ye et al., 2009): in the VZ and 
B 
C 
A 
D 
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SVZ of the lateral ventricles and in the developing cerebellum (Fig. 23) by ChIP. The two 
analyzed genomic regions on p57
kip2 
promoter contain an E-box (E-protein binding motif) and 
Tcf4 proximal promoter was used as negative control of binding as no E-Box motif could be 
identified in this region. We observed a strong enrichment of Tcf4 at p57
kip2 
promoter in vivo, 
supporting a role for the proneural gene in the regulation of p57
kip2 
gene transcription.    
 
 
Figure 23: Tcf4 occupies p57
kip2
 promoter in neural progenitors. ChIP analysis of Tcf4 occupancy at p57
kip2
 
promoter and Tcf4 proximal promoter in the regions surrounding the lateral ventricles of E15 mouse brain or in the 
developing murine cerebellum of P8. Brain punches from 6 animals for lateral ventricle were pooled and used for 
each immunoprecipitation (n=2) whereas 1 whole cerebellum was used for each immunoprecipitation (n=3). Values 
were first normalized to the Input, and then calculated as fold enrichment (Tcf4 antibody value divided by the IgG 
value) and plotted on a logarithmic scale. % of Input could not be used here as the value of the IgG differed grandly 
between the 3 primers. 
Altogether, we could show that Zac1 is an important transcriptional activator during 
neurogenesis. Via the control of Tcf4, it might promote neuronal differentiation. By controlling 
p57
kip2
 gene expression, Zac1 might also control the cell cycle exit of progenitor cells.   
 
V. Zac1 regulates Tcf4 expression during adulthood.  
In contrast to the other E-proteins (E2A and HEB) that are transiently expressed in the embryonic 
and early post-natal brain, Tcf4 expression increases during neurogenesis and remains strong in 
adult brain, especially in the cortex, in the hippocampus, the amygdala and the cerebellum 
(Brzózka et al., 2010). We asked whether Zac1 could regulate the expression of Tcf4 during 
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adulthood. We found that Tcf4 and Zac1 are co-expressed in the neurons of all regions of the 
hippocampus, in the cortex, in the basolateral nucleus of the amygdala (Fig. 24.A) and in the 
EGL and IGL neurons of the cerebellum (data not shown). We performed ChIP analysis and 
confirmed that Zac1 occupies the Tcf4 gene locus in the adult hippocampus and cerebellum, 
which suggests that Zac1 might regulate Tcf4 expression in these adult brain regions (Fig. 24.B).  
 
 
 
Figure 24: Zac1 and Tcf4 are co-expressed in specific adult brain regions. A) Zac1 and Tcf4 immunoreactivity 
patterns in the basolateral nucleus of the amygdala, in the hippocampus CA1, Dentate gyrus and Hilus, and in the 
cortex. 10 µM coronal sections were obtained from 3-month old cd1 mice and incubated with guinea pig anti mouse 
B 
A 
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Zac1 antibody (1/1000) and rabbit anti mouse Tcf4 antibody (1/1000). Scale bar: 100 µm B) Table to summarize 
Zac1, Tcf4 expression and co-localization in 4 brain regions. In the Zac1/Tcf4 expression column, is shown whether 
cells expressed low (+), moderate (++) and strong (+++) levels of Zac1 and Tcf4, as estimated by 
immunohistochemistry. In the Zac1/Tcf4 co-localization column is indicated whether a small subset (+), a majority 
(++) or all the cells (+++) co-expressed Zac1and Tcf4.  ChIP analysis of Zac1 occupancy at Tcf4 proximal promoter 
in the adult mouse brain. Low (+), mild (++) and strong enrichment of Zac1 at Tcf4 locus was observed in all 
analyzed brain regions.     
 Additionally ectopic expression of Zac1 in primary hippocampal (Fig. 25) and cerebellar granule 
cells of the EGL (data not shown) led to increased endogenous Tcf4 gene expression (2 fold) and 
increased Tcf4 protein levels. Altogether we suggest that Zac1 is a transcriptional regulator of 
Tcf4 in adult neurons.  
 
 
 
Figure 25: Zac1 transactivates Tcf4 in hippocampal neurons. A) Co-staining of Zac1 and Tcf4 of mature 
hippocampal neurons with anti-Zac1 and anti-Tcf4 antibodies showed that both factors are co-expressed in the nuclei 
of the neuronal cells (TuJ-1 positive cells). B) Hippocampal neurons were transfected with 100 ng of either Zac1 WT 
(Zac1) or the transactivation defective mutant construct (Zac1 ΔLPR); Tcf4 gene expression was measured by qRT-
B A 
C 
* 
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PCR 48hrs after transfection and normalized first to expression of the house keeping gene Mas, then to Mock 
transfected conditions. Zac1WT overexpression induces Tcf4 expression in hippocampal neurons, whereas deletion 
of the transactivator domain abolished completely Tcf4 induction. Bars represent the average of 3 independent 
experiments with duplicates; SD is shown. (*) p<0,05. C) Cells were transfected with 100 ng pRK-Zac1 GFP for 48 
hrs and co-stained with anti-GFP and anti-Tcf4 antibodies. Zac1 overexpression increases Tcf4 protein levels in 
primary hippocampal neurons. Scale bar: 100 µm    
 
VI. ZAC1 might regulate TCF4 expression in Human. 
We analyzed the conservation between the mouse and human Tcf4 promoter and first intron DNA 
sequences for potential Zac1 binding sites (Fig. 26). Computational analysis showed that both 
promoter and intron sequences are highly conserved (78% identical) between the two species 
supporting a role for these genomic elements in the control of the gene transcription. Putative 
Zac1/ZAC1 binding sites on TCF4 promoter and on the first intron were conserved across 
species, suggesting that ZAC1 could bind to TCF4 promoter and first intron to regulate TCF4 
gene expression.  
To examine if Zac1-mediated Tcf4 induction is conserved in human, we next transfected ZAC1 
into the human neuroblastoma cell line SK-N-MC. ZAC1 increased TCF4 mRNA in a dose 
dependent manner suggesting cross-species conservation (Fig. 27).  
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Figure 26: Conservation of the multiple Zac1/ZAC1 binding sites on Tcf4/TCF4 locus. Alignment reveals 
conservation of Tcf4 promoter sequences between mouse (m) and Human (H). Identity, gaps were symbolized with 
(*) and (-) respectively. Relative bp positions to the transcriptional start sites are indicated. For both species, the 
multiple potential Zac1/ZAC1 binding sites that resemble the idealized direct repeat type (G4N1–12G4)2 were framed 
with blue rectangles and binding sites previously identified in mouse were framed with green rectangles. 
Results 
 
65 
 
 
Figure 27: ZAC1 regulates TCF4 expression in SK-N-MC cells. Cells were transfected with increasing amount of 
PRK-Flag ZAC1 for 24 hrs, and expression of TCF4 was measured by qRT-PCR and normalized first to the house 
keeping gene GAPDH gene expression, then to Mock transfected cells. Bars represent the mean of 2 independent 
experiments performed in duplicates; SD is shown.  
 
VII.  Antibody validation 
We have generated two rabbit polyclonal antibodies that recognize different epitopes on the Tcf4 
protein. We created an antibody that could recognize total Tcf4 proteins and one that recognizes 
specifically the isoform that is induced by Zac1, namely the isoform B (Fig. 28). 
To validate sera immunoreactivity, we performed immunoblot and immunocytochemistry 
analysis. We used 2 different cell lines: the LLC-PK1 cells which can be electroporated with high 
efficiency and the DLD1-ITF2 cell line that stably overexpresses Flag-tagged TCF4-B when 
cultured in presence of doxycycline (Herbst et al., 2009a). Whole cell extract (WCE) of LLC-
PK1, transfected with Flag-tagged TCF4-A or Flag tagged TCF4-B, were blotted with a mouse 
anti-Flag and the 2 rabbit anti-Tcf4 antibodies. Immunoblot analysis confirmed that Tcf4 and 
Tcf4-B antibodies could be used to detect TCF4 protein level. The Tcf4-B antibody could detect 
specifically the isoform B, whereas Tcf4 antibody could detect both isoforms. No signal was 
detected in the mock transfected conditions (Fig. 29.A). We further confirmed the specificity of 
the signal by blotting WCE of DLD1-ITF2 cells with the mouse monoclonal antibody Ri-3b9 that 
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recognizes the 2 human isoforms of TCF4. Strong signals were detected at the same molecular 
weight in the WCE of cells cultured in presence of doxycycline, whereas no signal was observed 
with WCE of non-induced cells (Fig. 29.B). Tcf4 protein is highly conserved between Human 
and mouse, and we confirmed that both sera could also be used to detect mouse Tcf4 proteins 
(Fig. 29.C). Finally, we validated the antibodies for immunocytochemistry experiments by co-
staining LLC-PK1 cells transfected with Flag-tagged TCF4-B, with Tcf4 and Ri-3b9 antibodies 
(Fig. 29.D). 
 
 
Figure 28: Protein sequence alignment of the 2 isoforms of mouse and human Tcf4. Epitopes of Tcf4-B and Tcf4 
antibodies are framed in the blue and red box respectively. Identity and gaps were respectively symbolized with (*) 
and (-). Alignment showed extremely high conservation of protein sequences between the two species.  
 
Results 
 
67 
 
 
Figure 29: Validation of Tcf4 antibodies for immunoblot and immunocytochemistry. A) Immunoblot analysis of 
LLCPK-1 WCE. Cells were transfected with 4 µg of PRK-Flag TCF4-A, PRK-Flag TCF4-B or 4 µg parent vector as 
mock. WCE were prepared 24 hrs after transfection, and blotted with mouse anti Flag (1/1000), rabbit anti Tcf4-B 
(1/500) and rabbit anti Tcf4 (1/1000) antibodies. B) Immunoblot analysis of DLD-1 WCE. TCF4-B expression was 
induced for 48 hrs by adding doxycycline (+Dox) in the growing medium.  WCE of non induced cells (-Dox) and 
induced cells (+Dox) were blotted with mouse anti hemagglutinin HA (1/1000), mouse monoclonal anti TCF4 (Ri-
3b9), rabbit anti Tcf4-B (1/500) and rabbit anti Tcf4 (1/1000) antibodies. Size marker (*) and corresponding 
molecular weights are shown. C) Immunoblot analysis of LLCPK-1 WCE. Cells were transfected with increasing 
amount of mouse Tcf4 expression vector or with PAM as mock. WCE were prepared 24 hrs after transfection, and 
blotted with mouse anti Flag (1/1000), rabbit anti Tcf4-B (1/500) and rabbit anti Tcf4 (1/1000) antibodies. D) 
Immunocytochemistry analysis of LLC-PK1 cells transfected with 1 µu PRK-Flag-TCF4-B. Cells were co-stained 
with a mouse anti Flag (1/1000) and with rabbit antibody anti Tcf4 (1/1000) or with the mouse monoclonal anti 
TCF4 (Ri-3b9 - 1/200) and with the rabbit anti Tcf4 (1/1000). Scale bar: 100 µm. 
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I. The imprinted gene Zac1 regulates the expression of the proneural 
factor Tcf4. 
The seven-zinc finger protein Zac1 is a transcriptional regulator controlling apoptosis and cell 
cycle arrest. It is strongly expressed in proliferative compartment of the developing brain and in 
the lower layers of the cortex where it might mediate control of proliferation and differentiation 
of neural progenitors (Alam et al., 2005; Valente et al., 2005). However, until now, no Zac1-
regulated genes have been identified providing insight into Zac1-dependent pathways during 
brain development. Using genome-wide expression analysis, we identified the proneural gene 
Tcf4 as bona fide Zac1 target gene. Tcf4 has been shown to mediate neuronal differentiation of 
specific populations in the hindbrain but also to control cellular proliferation and cell migration 
(Flora et al., 2007; Sobrado et al., 2009). TCF4 plays a critical role during human brain 
development which was unraveled by genetic studies that identified haploinsufficiency of TCF4 
as cause of the Pitt Hopkins syndrome. We could show that Zac1 coordinately binds to the 
proximal promoter and first intron of Tcf4 in vitro and in vivo and induces specifically its 
expression in several mouse neural cell types (embryonic stem cells, neural stem cells and 
specific mature neuronal populations). We could also show that ZAC1, the human Zac1 
orthologue could regulate TCF4 in vitro, suggesting cross species conservation. However 
reporter assays and ChIP experiments in human cell line and tissue are still required to validate 
TCF4 as ZAC1 direct target gene. 
Our work shows that Tcf4 expression is regulated by Zac1 during brain development and in 
specific regions of the adult brain. However its relative importance in the control of Tcf4 gene 
expression remains unclear. A targeted Zac1 knock-down approach as well as a comparison 
between WT and Zac1 KO mice during development could further strengthen the hypothesis of 
an important contribution of Zac1 to Tcf4 expression. 
Although Zac1 is expressed in both glia and neurons, it seems to mediate Tcf4 expression mainly 
in neuronal progenitor cells or mature neurons hinting to a cell specific control of Tcf4 gene 
transcription, as suggested by chromatin immunoprecipitation and reporter assay experiments. 
Hence, the regulation of Zac1 binding to Tcf4 locus might be one of the molecular events 
contributing to Tcf4 cell specific gene expression. However, the precise molecular mechanism as 
well as the individual roles of Tcf4 promoter and first intron need to be addressed.    
One hypothesis could be that epigenetic mechanisms regulate the Tcf4 promoter and the first 
intron activity. Tcf4 expression is regulated in human cancer by histone acetylation (Herbst et al., 
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2009a) but also by CpG methylation. Indeed, methylation levels are higher in intestinal-type 
gastric cancer and correlate with decreased TCF4 expression (Kim et al., 2008, Joo et al., 2010). 
Interestingly, the proximal promoter and the first intron of Tcf4 harbor a CpG island, and 
previous studies indicated that Zac1 cannot bind to palindromic DNA elements when their 
cytosines are methylated (Arima et al., 2005). It is therefore tempting to hypothesize that DNA 
methylation of the Tcf4 promoter and first intron might differ between neuronal and glial cell 
types, and hence impair or prevent Zac1 DNA binding.  
Our computational analysis also revealed that the first intron of Tcf4 which is highly conserved 
between the human and mouse genome (73% identity), contains many putative binding sites for 
transcription factors involved in brain development and histone modifiers (e.g Hes1, Hes5, E47, 
Sox2, Sox5, Stat3, Zic2, CBP, p300, Kdm5b) (Nagai et al., 2000; Fukuda and Taga, 2005; 
Kiefer, 2007; Xie et al., 2011). Additionally, this genomic element is a DNAseI sensitive site in 
mouse embryonic stem cells, in the embryonic cerebrum and cerebellum (E14.5) and adult brain 
(UCSC genome browser - chr18:69,503,893-69,507,335 - [http://genome.ucsc.edu/cgi-
bin/hgTracks]). All these features depict enhancer elements; however the Tcf4 first intron does 
not function as an enhancer sensu stricto. Indeed our reporter assays indicated that it does not 
increase promoter activity and its activation depends on its orientation relative to the naïve 
promoter. As its association with the naive Tcf4 proximal promoter is required to observe Zac1-
induced upregulation of Tcf4 promoter activity in a cell specific manner (Fig. 16.B), we 
hypothesize that the intronic element functions as a regulatory element. We suggest that cell-
context dependent signaling associated with specific chromatin signatures might mediate the 
specific activation of Tcf4 by Zac1.    
II. Zac1 as regulator of cell differentiation  
During brain development, the cross talk between proneural and maintenance factors governs cell 
fate decision and the timing of differentiation. The balance between these factors regulates the 
transcriptional programs that determine whether cells will pass through proliferative or 
neurogenic division. Zac1 might be one of the factors influencing this equilibrium by promoting 
neuronal differentiation via different mechanisms.  
Zac1 might counter-act the effect of the Id proteins by increasing the protein levels of the E-
protein Tcf4. During neurogenesis, RGC proliferation is under the control of Id proteins which 
prevent binding of the bHLH factors to the promoter of genes involved in differentiation (Lyden 
et al., 1999; Jung et al., 2010). Id proteins were shown to sequester E-proteins and prevent their 
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association with proneural factors. Hence, Zac1 could promote neuronal differentiation by 
increasing Tcf4 levels, and thus increasing the binding of transcriptional activator complexes to 
neurogenic gene promoter. In this case, Zac1 is possibly involved in the transcriptional programs 
controlling neuronal differentiation.  
Additionally Zac1 could counter-act the effect of Hes/Id genes by promoting cell cycle arrest of 
the neural progenitors. Rotschild et al (Rothschild et al., 2006), showed that Id and E-proteins 
compete to regulate p57
kip2 
expression in order to induce cell cycle arrest in developing 
neuroblasts. Here we suggest a novel degree of fine tuning for this mechanism by showing that 
Zac1 regulates the expression of the cell cycle regulator p57
kip2
. We could confirm that Zac1 
regulates p57
kip2
 indirectly via up-regulation of Tcf4. However our data also indicate that Zac1 
binds to p57
kip2
 promoter, suggesting a direct transactivation mechanism as indicated by previous 
studies (data not shown). Here, we show that both factors, Zac1 and Tcf4, might induce p57
kip2
 
gene expression; however we could not assess the relative contribution of Zac1 and Tcf4. Further 
experiment using Tcf4 knock-down approaches could provide information about this regulatory 
mechanism. Firstly, the effects of transient silencing of Tcf4, by RNA interference, on p57
Kip2
 
gene expression, could be determined in vitro. In addition, comparison of p57
kip2 
mRNA and 
protein levels in Tcf4 WT and KO mice could indicate whether Tcf4 is an important regulator of 
the cell cycle regulator p57
kip2
. Finally, primary cerebellar neurons, or neural progenitors of the 
VZ obtained from Tcf4 knockout mice could be transfected with Zac1 expressing plasmid. In 
these cells, p57
kip2
 expression should then be determined. Increased expression of p57
kip2
 upon 
Zac1 overexpression would indicate that Zac1 can activate p57
Kip2
 via Tcf4-independent 
mechanisms.    
p57
kip2 
regulates cell cycle dynamics of RGC and IPC, controls precursor pool size, neuronal 
differentiation, cortical size and laminar patterning (Tury et al., 2011a, 2011b; Mairet-Coello et 
al., 2012). Zac1 and p57
kip2
 have been shown to interact in the context of an imprinting gene 
network that regulates early mouse development (Varrault et al., 2006) and they show a strikingly 
similar expression pattern during development (Alam et al., 2005; Ye et al., 2009). Interestingly, 
during corticogenesis, cells leaving the cell cycle early (E11- E14) generate layers 4-6 of the 
cortex whereas those born later (E15-E17) populate layers 2-3 (Polleux et al., 1997). As the 
timepoint that precursors exit the cell cycle correlates with their laminar destination, mechanisms 
that regulate the cell cycle machinery also impact neuronal fate. Zac1 could thus contribute to the 
timing of neuronal differentiation and to their fate by activating Tcf4 and p57
kip2
 expression. 
p57
kip2
 and Tcf4 have also been shown to regulate cell migration. Zac1 could therefore contribute 
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to establishing brain patterning by regulating migration of neuronal precursors. We hypothesize 
that Zac1, like proneural factors, acts via different mechanisms during neurogenesis. We suggest 
that it might regulate the transcriptional programs and the correct timing of differentiation, hence, 
controlling the fate of neural progenitors.  
Functional approaches such as in vivo Zac1 overexpression or knock down in RGC or IPC should 
be used to determine whether Zac1 expression can initiate differentiation and override the effect 
of Id or Hes genes in the control of proliferation. Furthermore, the migration pattern of Zac1-
overexpressing cells could be determined to confirm whether Zac1 controls the fate of neural 
precursors.     
 
III. Future directions:  Zac1, Tcf4 and schizophrenia 
Schizophrenia is a spectrum disorder with ~1% lifetime prevalence and is a strongly inherited 
disease with a heritability of 80% or more. Disease onset occurs usually during adolescence, and 
suicide is the leading cause of premature death. Although the genetic basis for the disease has 
been clearly established, the underlying genetics of schizophrenia is still partially answered. It is 
now believed that accumulation of single gene mutations, lead to the onset of the disorder, as 
each single mutation identified until now, has only modest phenotypic effects. A recent meta-
analysis across SNP data from several genome-wide scans revealed that the risk of schizophrenia 
was associated with a marker in the intron 4 of TCF4 (Stefansson et al., 2009). Another study in a 
large Han Chinese cohort identified another SNP in the close neighboring of the previous study, 
further confirming the association between genetic variation in TCF4 intragenic regions and 
schizophrenia (Li et al., 2010). Interestingly, a recent study identified the miR-137 (Ripke et al., 
2011) and four of its putative targets (CSMD1, C10orf26, CACNA1C and TCF4) (Kwon et al., 
2011) as reaching genome-wide significant association with schizophrenia. miR-137 plays a role 
in the control of adult neurogenesis and neuronal maturation, mechanisms through which 
variation at this locus contribute to brain development abnormalities in schizophrenia (Szulwach 
et al., 2010). These findings indicate that dysregulation of miR-137 may be a new pathway that 
contributes to schizophrenia, by leading to misregulation of its target genes, including TCF4. 
The involvement of TCF4 in schizophrenia has been recently identified and therefore, only few 
studies attempted to address its role in the disease progression (Brzózka et al., 2010; Lennertz et 
al., 2011; Quednow et al., 2011). It was shown that both transgenic mice moderately 
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overexpressing TCF4 postnatally in the brain as well as individuals carrying the risk allele 
display reduction in sensorimotor gating (Brzózka et al., 2010), which is an endophenotype of 
schizophrenia. In addition, human induced pluripotent stem cells-derived neurons from 
schizophrenic patients express higher levels of TCF4, which could be reduced to control level 
after treatment with the antipsychotic medication, loxapine (Brennand et al., 2011). Altogether, 
this suggests that the fine tuning of TCF4 gene expression is important for the development of 
brain circuitries involved in certain aspects of schizophrenia, which could be established during 
early brain development, or in the adult brain. Herein we showed that Zac1 can regulate Tcf4 
expression pre and postnatally, and that their expression colocalize in distinct brain regions 
implied in the etiology of schizophrenia and involved in sensorimotor gating (hippocampus, 
basolateral amygdala, cortex). Hence, it would be of interest, to investigate whether modulation 
of Zac1 expression in vivo by drug treatment, could regulate the Tcf4 gene expression and impair 
cognitive performance and affective behavior of animal models.  
To our knowledge, there is no report of correlation between the Zac1 gene expression and 
antipsychotic treatments (typical and atypical). It is therefore unlikely that these drugs directly 
impair Zac1 expression. Interestingly, PACAP signaling has been shown to be regulated by Zac1, 
and impaired PACAP signaling was recently associated with the pathophysiology of 
schizophrenia (Hashimoto et al., 2007). PACAP Knockout mice display schizophrenia-related 
behavior, which could be reverted by antipsychotic treatment (Hashimoto et al., 2007). Although 
the direct relation between the PACAP signaling and Zac1 has been demonstrated in the 
cerebellum (Fila et al., 2009), this interaction has to be proven in other brain regions involved in 
the etiology of schizophrenia (e.g prefrontal cortex, hippocampus, amygdala and striatum). To 
address this, direct infusion of PACAP, or stimulation of PACAP signaling in vivo with lithium 
(Brandish et al., 2005) could be performed. Expression levels of Zac1 and its target genes could 
be then assessed.  Ultimately the importance of Zac1 in the positive effects of PACAP signaling 
could be determined by increasing Zac1 expression in PACAP null mice. Further investigation on 
the interaction between the PACAPergic system, Zac1,Tcf4 and p57kip2 during neural 
development are required to determine whether Zac1 plays a role in cognitive functions.     
Besides a strong genetic origin of the disease, schizophrenia onset has been also linked to 
environmental factors (Sullivan et al., 2003). Indeed, the association between influenza exposure 
during pregnancy and schizophrenia symptoms has been confirmed by several studies and 
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extended to many other pathogens including other viruses (HSV-2, rubella), bacteria, and 
protozoa (Brown and Derkits, 2010). In animal models, prenatal immune challenge was found to 
disrupt brain maturation and to induce behavioral alterations related to schizophrenia (deficits in 
pre-pulse inhibition, latent inhibition, and amphetamine hypersensitivity (Boksa, 2010)) and 
display developmental and pharmacological features concordant with the disease (Shi et al., 
2003; Zuckerman et al., 2003). Interestingly, Zac1 expression is regulated through TLR3, IRF3 
dependent pathways and is induced by viral infection in murine embryonic fibroblasts (MEFs), 
however the physiological function of this induction remains unknown (Warzée et al.,2010; 
Andersen et al., 2008). We could reproduce these findings in the neural stem cell line C17.2 and 
in hippocampal neurons, where treatment with the viral mimic, polyinosinic:polycytidylic acid  
(poly I:C) induced both Zac1 and Tcf4 expression, associated with an increased binding of Zac1 
to TCF4 locus (data not shown). Hence, upon infection during pregnancy, Zac1 expression might 
be induced in neural progenitors and neurons, and in turn up-regulate Tcf4 gene expression, 
which could contribute later to the development of the behavioral alterations related to 
schizophrenia. To address this, Zac1 and Tcf4 expression should be determined throughout early 
embryonic development and postnatally in a mouse model of prenatal infection with the viral 
mimic, Polyinosinic:polycytidylic acid  (poly I:C) (Meyer et al., 2010). 
Conclusion 
 
75 
 
Conclusion 
The imprinted gene Zac1 is a regulator of progenitor cell fate during development. Zac1 is a 
transcription factor that is temporarily expressed in the neuroepithelia and in differentiating 
neuronal precursors during neurogenesis. We have shown here, that Zac1 can regulate the 
expression of the E-protein Tcf4 and represents a factor promoting neuronal differentiation. As 
Zac1 activates the expression of the obligatory partner of proneural genes, it might compete with 
the Id and/or Hes genes to initiate transcriptional cascades required for neuronal differentiation. 
Besides, by controlling Tcf4 and its target p57
Kip2
 gene expression, Zac1 could also regulate the 
cell cycle and the fate of the neural precursors. Finally in the adult brain, Zac1 contributes to the 
fine tuning of Tcf4 expression which is important for cognitive performance and affective 
behavior (Fig. 30). Altogether we could show that Zac1 mediates neural progenitor cell 
differentiation, and could play a role in the establishment of the neuronal networks that control 
particular cognitive functions later in life.  
 
Figure 30: Model: Zac1 regulates the Tcf4 gene and its target p57
kip2
 gene in the embryonic and adult brain. 
Zac1, Tcf4 and p57
Kip2
 might compete with the Id / Hes genes to regulate neuronal precursor cell differentiation and 
migration. The interaction between Zac1 and Tcf4 in adult might mediate cognitive functions, like sensorimotor 
gating, however this question still needs to be addressed.  
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